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Abstract 
 Upregulation of the mitochondrial unfolded protein response (mtUPR) as a result of 
alterations in mitochondrial protein stoichiometry has been proposed as a common pathway in 
longevity. While mtUPR upregulation correlates with lifespan extension in lower organisms, it is 
not known whether mtUPR is elevated in long-lived mice. We hypothesized that long-lived 
mutant mouse models would have enhanced mtUPR. 
 We found that Snell dwarf mice ("Snell mice"), one of the longest-lived mouse models with 
30-40% lifespan extension, exhibit augmented mitochondrial stress response. Primary fibroblasts 
from Snell mice show elevated levels of the mitochondrial chaperone HSP60 and mitochondrial 
protease LONP1, two components of the mtUPR. In response to mitochondrial stress, the 
increase in the expression of Tfam, a regulator of mitochondrial transcription, is higher in Snell 
cells, while Pgc-1α, the main regulator of mitochondrial biogenesis, is upregulated only in Snell 
cells. Consistent with these differences, after exposure to mitochondrial stress by doxycycline 
treatment, oxidative respiration rate and cellular ATP content, indicators of mitochondrial 
function, are higher in Snell cells than those in normal cells. In vivo, Snell mice show robust mtUPR 
induction after mitochondrial stress exposure by doxycycline treatment, as demonstrated by a 
40-50% increase in HSP60 and LONP1 protein levels in liver tissue samples. In contrast, normal 
mice fail to show such a response despite exhibiting aggravated disturbance of mitochondrial 
protein stoichiometry.  
 We noted elevated protein levels of LONP1 and TFAM in Snell liver without comparable 
increases in corresponding mRNA levels, suggesting an upregulation at the translational level. 
Based on recent findings showing that mRNA transcripts bearing 5'UTR N6-methyladenosine 
xix 
 
(m6A) modifications are selectively translated by m6A-mediated cap-independent translation 
(m6A-CIT), we hypothesized that LONP1 and TFAM protein levels may be elevated through m6A-
CIT. Consistent with our hypothesis, Lonp1, Tfam, and Pgc-1α carry the consensus motif for m6A 
modification, and are listed among putative targets of m6A-CIT. We found that liver, kidney, and 
skeletal muscle of Snell mice have elevated protein levels of METTL3 and METTL14, which add 
m6A marks to target mRNAs, and of YTHDF1 and YTHDF2, which promote translation of m6A-
tagged mRNAs. In contrast, ALKBH5 and FTO, which downregulate cap-independent translation 
of target transcripts by removing m6A marks, are not upregulated. By knocking-down METTL3 in 
HEK 293 cells, we demonstrated that protein levels of TFAM and PGC-1α, but not of LONP1, are 
regulated by m6A-CIT. These findings support the hypothesis that the m6A-CIT pathway is 
upregulated and might contribute to upregulation of TFAM and PGC-1α in Snell mice. 
 Our work demonstrates improved mitochondrial stress response in a long-lived mouse model, 
and provides a rationale for future mouse lifespan studies involving compounds that induce 
mtUPR. Our data indicating upregulation of the m6A-CIT pathway in Snell mice support the 
hypothesis that m6A-CIT may partially account for elevated protein levels of TFAM and PGC-1α. 
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Chapter 1 -  Introduction 
1.1  Aging 
Aging can be defined as the process of progressive decline in the function and form of 
organisms starting at adulthood. It is generally thought to be driven by concurrent deterioration 
of multiple cellular structures and molecular pathways – a comprehensive understanding of this 
process is still lacking. Aging research investigates the molecular mechanisms underlying aging-
associated deterioration with the aim of utilizing the ensuing insights to develop interventions 
to slow down the aging process and prolong lifespan and healthspan in mammals.  
1.1.1 The idea of lifespan extension as a scientific query 
Lifespan extension (and even immortality) has been sought by many throughout recorded 
history. However, the study of lifespan extension as a proper area of scientific research is very 
recent, and not yet complete. Historically, the pursuit of a longer lifetime has not been 
associated with science; to the contrary, it was considered to belong to the realm of the 
supernatural – or simply impossible. Until the late 20th century, a portion of the scientific 
community was quite confident that the laws of nature would not allow an expansion of the 
pre-determined limit on the time a living creature can spend on earth. This belief had to change 
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in the 21st century. Reports of lifespan extension in yeast (Fabrizio, Pozza, Pletcher, Gendron, & 
Longo, 2001), round worms (M. R. Klass, 1983), and fruit flies (Tatar et al., 2001), followed by 
those in naturally occurring mutant mice (Brown-Borg, Borg, Meliska, & Bartke, 1996; Flurkey, 
Papaconstantinou, Miller, & Harrison, 2001) firmly established that alteration of a single gene 
was sufficient to extend lifespan - even in mammals.  
1.1.2 Lifespan extension across species 
The first documented observation of lifespan extension by a genetic mutation took place only 
35 years ago with the description of eight long-lived strains of the roundworm C. elegans by 
Klass (M. R. Klass, 1983). This early report provided insightful clues for aging research: (i) Two of 
the eight mutant strains entered a semi-quiescent nematode-specific developmental state 
named “dauer larva state”, which had been known to extend chronological lifespan (M. Klass & 
Hirsh, 1976). This early observation showed that future lifespan studies on C. elegans should 
watch for dauer formation and interpret the results accordingly. (ii) Five out of remaining six 
mutant strains of worms had partial paralysis of the pharynx resulting in decreased food 
(bacteria) ingestion. The last mutant strain showed a lack of interest in food, leading to reduced 
food intake. Moreover, among the five strains showing defective food ingestion, a direct 
correlation was noted between the amount of lifespan extension and the decrease in food 
intake. These findings supported the idea that restricted food intake may prolong lifespan in 
worms as had been suggested previously (M. R. Klass, 1977). Indeed, caloric restriction has 
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been proved to be a robust way of extending lifespan not only in worms, but also in higher 
organisms, including mammals (Flurkey, Astle, & Harrison, 2010).  
1.1.3 Long-lived mutant mice I - Naturally occurring long-lived mice 
Work published starting from the mid-1990s established that certain strains of dwarf mice had 
a striking phenotype: They showed retarded growth but lived longer their normal siblings. 
1.1.3.1 Snell dwarf mice 
Snell dwarf mice ("Snell mice") were first described by G.D. Snell in 1929 as naturally occurring 
mice exhibiting hereditary dwarfism as a recessive mendelian character (Snell, 1929). He also 
noted that these mice were "fairly healthy despite their greatly reduced size" (Snell, 1929). 
Seven decades after this report, a comprehensive lifespan study performed on two 
independent colonies located at two sites found that Snell mice show more than 40% increase 
in mean and maximum lifespan compared to normal littermates (Flurkey et al., 2001).  
Snell mice were the first mutant mice described to show genetically transmitted dwarfism (S. Li 
et al., 1990). They carry an autosomal recessive mutation in the Pit1 gene located on 
chromosome 16. PIT1 (pituitary-specific positive transcription factor 1) is a transcription factor 
required for proper development of anterior pituitary gland, a structure residing below the 
hypothalamus at the base of the brain (Fig. 1.1). In Snell mice, a single G-to-T point mutation in 
the Pit1 gene results in the substitution of tryptophan (Trp261) with cysteine and renders the 
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transcription factor dysfunctional by abolishing its DNA binding (S. Li et al., 1990). Of note, the 
tryptophan residue found to be altered in Snell mice is conserved in PIT1 homologues from 
yeast to mammals, consistent with its functional role.  
The anterior pituitary gland includes distinct cell populations for the synthesis and secretion of 
five hormones (Andersen et al., 1995). Pituitary cell types are listed below in the order they 
emerge during development:  
 • Adrenocorticotropic hormone (ACTH), β-lipotropin, and melanocyte-stimulating hormone 
are secreted by corticotropes under the control of corticotropin-releasing hormone (CRH) 
produced in the hypothalamus.  
 
Figure 1.1 Pituitary gland. 
Pituitary gland is located in a structure called "sella turcica" ("Turkish seat" in Latin) below the 
hypothalamus. 
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 • Thyroid-stimulating hormone (TSH) is secreted by thyrotropes under the regulation of 
thyrotropin-releasing hormone (TRH) produced in the hypothalamus.   
 • Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are secreted by 
gonadotropes under the regulation of gonadotropin-releasing hormone (GnRH) produced in the 
hypothalamus.  
 • Growth hormone (GH) is secreted by somatotrope cells in response to growth hormone-
releasing hormone (GHRH) produced in the arcuate nucleus of the hypothalamus. GH secretion 
can be inhibited by growth hormone-inhibiting hormone (GHIH), also produced in the 
hypothalamus.  
 • Prolactin (PRL) is released by lactotropes in response to multiple hormones produced in 
hypothalamus, including TRH.  
Snell mice (Pit1dw/dw) exhibit abnormal pituitary gland development. The Pit1dw/dw mutation 
primarily affects the anterior lobe of the pituitary gland (Carsner & Rennels, 1960). In normal 
mice, PIT1 protein expression can be detected in GH producing somatotrophs, PRL producing 
lactotrophs, and TSH producing thyrotropes (Simmons et al., 1990). As expected from the PIT1 
expression pattern, no growth hormone (Wilson & Wyatt, 1986b), prolactin (Wilson & Wyatt, 
1986b), or thyroid-stimulating hormone (Wilson & Wyatt, 1986a) can be detected in the 
pituitary of Snell mice. 
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Growth hormone stimulates hepatic production of insulin-like growth factor 1 (IGF-1), which 
mediates GH effects. Since Snell mice are deficient in GH (Sinha, Salocks, & Vanderlaan, 1975), 
they exhibit diminished levels of circulating insulin-like growth factor 1 (van Buul-Offers et al., 
1994).  
Lack of thyroid stimulating hormone leads to hypothyroidism in Snell mice. In rats, 
hypothyroidism is linked to decreased proton leakage in mitochondria (Brand, 1990), which is 
thought to stem from decreased conductance of mitochondrial inner membrane (Nobes, 
Brown, Olive, & Brand, 1990). Snell mice maintain a lower body core temperature compared to 
normal mice, probably due to hypothyroidism or GH deficiency, or to the requirements of 
maintaining temperature with a relatively high ratio of surface area to volume.  
Snell mice develop normally until the 14th postnatal day, but some of them can be identified on 
the 12th day by their shorter noses and tails (Snell, 1929). Young adults are approximately one-
third the weight of heterozygous or wild type littermates (Flurkey et al., 2001). Although they 
may have immunodeficiency of the thymus-dependent lymphoid system, which has been 
reported for the closely related Ames dwarf mice (Duquesnoy, 1972), Snell mice show partial 
protection from the age-associated decay in immune function (Flurkey et al., 2001).  
1.1.3.2 Ames dwarf mice 
Ames dwarf mice (“Ames mice”), first documented in 1961 in the University of Iowa (in Ames, 
Iowa), have a point mutation in the Prop1 (homeobox protein prophet of Pit-1) gene located on 
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chromosome 11, the protein product of which is required for induction of Pit1 expression 
(Andersen et al., 1995). Ames mice (Prop1df/df) closely resemble Snell mice (Pit1dw/dw). They 
have smaller adult body size and an underdeveloped pituitary gland, leading to reduction in 
circulating levels of GH, TSH, and prolactin. Plasma IGF-1 levels are undetectably low in Ames 
mice (Chandrashekar & Bartke, 1993). Body core temperature average is 1.6 degree Celsius 
lower than normal mice (Hunter, Croson, Bartke, Gentry, & Meliska, 1999). Ames mice live 
longer than their normal littermates; the average lifespan increase is around 45% in males and 
60% in females (Brown-Borg et al., 1996).  
Ames mice show decreased levels of circulating glucose and insulin. Plasma glucose levels are 
~20-30% lower in Ames mice, independent of sex (Borg, Brown-Borg, & Bartke, 1995). In 
normal mice, circulating insulin levels are ≥2-fold higher in males compared to females. 
However, Ames males, but not females, show lower insulin levels compared to normal sex-
matched controls. As a result, the sex difference in insulin levels disappears in Ames mice (Borg 
et al., 1995). Ames mice are also insulin sensitive, which explains reduced blood levels of 
insulin. 
The effects of the Ames mutation on plasma corticosterone concentration is in opposite 
directions in males and females. Corticosterone levels in normal males are only ~10-15% of 
those in normal females. While Ames males show 4-5 fold higher corticosterone levels 
compared to sex-matched controls, Ames females have 40-50% lower corticosterone (Borg et 
al., 1995). Ames mice show immunodeficiency of the thymus-dependent lymphoid system 
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(Duquesnoy, 1972), presumably as a consequence of thyroid dysfunction due to deficient TSH 
signaling.  
1.1.3.3 Little mice 
The “little” (lit) mutation was reported in 1976 as a new autosomal recessive mutation on 
chromosome 6, associated with dwarfism in mice (Eicher & Beamer, 1976). In the early 90s, the 
“little” mutation was identified as a missense mutation in the growth hormone releasing 
hormone receptor gene (Ghrhrlit/lit) (Godfrey et al., 1993), providing another instance of 
naturally occurring mutation affecting the GH/IGF-1 signaling pathway.  
GHRHR is expressed in the somatotrope cells of the pituitary gland and activated by the 
hypothalamic GHRH to stimulate GH synthesis and secretion (Godfrey et al., 1993). As opposed 
to Snell and Ames mutations, which lead to multiple hormone deficiencies, Ghrhrlit/lit mutation 
could be expected to lead to an isolated defect in GH/IGF-I signaling. However, the effect of the 
mutation is not restricted to GH signaling. Anterior pituitary glands of Ghrhrlit/lit mice show 
reduction in both GH and PRL (Eicher & Beamer, 1976), suggesting a possible effect of GH 
signaling pathway on the regulation of other pituitary hormones. Further research is needed to 
elucidate the inter-regulatory effects of distinct cell populations in the pituitary gland.  
Little mice show prolonged lifespan. The increase in average lifespan is 23% in males, and 25% 
in females (Flurkey et al., 2001). They exhibit reduced growth. After 4 weeks of age their body 
weight is approximately half that of control mice (Eicher & Beamer, 1976). They are fertile but 
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show some reproductive deficiencies. Although females may lose their first litters due to failure 
of milk production, subsequent litters are raised normally. Males show reduced fertility; half of 
them produce only one litter, and only a few produce more than two litters (Eicher & Beamer, 
1976).  
1.1.4 Long-lived mutant mice II: Genetically engineered long-lived mice 
Prolonged longevity observed in the naturally occurring mutants Ames dwarf and Snell dwarf 
which show impaired GH/IGF-1, TSH, and PRL signaling, and in Ghrhrlit/lit mice deficient in 
GH/IGF1 signaling, suggested a causative role for these pathways on mouse lifespan. With the 
aim of dissecting individual contributions of each pathway, multiple strains of genetically 
modified mice harboring defects in these pathways have been examined in the last 20 years.  
1.1.4.1 Growth hormone receptor knockout mice  
The first genetically modified mouse model with defective GH signaling was created in 1997 by 
replacing some portion of exon 4 and downstream intron sequence of growth hormone 
receptor (Ghr) gene with a neo cassette (Y. Zhou et al., 1997). The resulting mutants have been 
referred as “GHR-KO” or “GHR/BP disrupted” mice. GHR-KO mice have defective GH signaling 
and reduced levels of circulating IGF-1. However, they show elevated plasma levels of GH due 
to absence of a GHR-mediated negative feedback signal. Their body weight is comparable to 
normal mice at birth, but around 40% of normal controls at adulthood. In contrast to dwarf 
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mice, they are mostly fertile, but exhibit various reproductive defects (Bartke & Brown-Borg, 
2004). 
Up to 50% increase in lifespan is reported in GHR-KO mice colonies with multiple genetic 
backgrounds (Coschigano, Clemmons, Bellush, & Kopchick, 2000; Coschigano et al., 2003). The 
long-lived GHR-KO mice also show signs of partial resistance to age associated health 
deteriorations. The ability to acquire new information and to recall it at a later time is blunted 
by age. In tasks requiring retention of 4-week-old memories, normal old mice perform around 
40% worse than young mice with the same genetic background. However, old GHR-KO mice 
perform as well as young controls, and exhibit a total rescue of the cognitive decay observed in 
old mice (Kinney, Coschigano, Kopchick, Steger, & Bartke, 2001). These observations in GHR-KO 
mice suggest that diminished GH/IGF-1 signaling may ameliorate the age-associated cognitive 
decline. Still, considering the highly elevated levels of circulating GH in these mice and the 
diminished PRL levels in the pituitary gland of Ghrhrlit/lit mice (Eicher & Beamer, 1976) indicating 
a possible of cross-talk between cell populations residing in the pituitary, it is necessary to 
perform further studies to rule out the potential effects of other hormones on the improved 
cognitive phenotype. Indeed, a follow-up study reported lower PRL receptor and elevated PRL 
levels in GHR-KO mice (Chandrashekar et al., 2007), making it harder to explain the GHR-KO 
phenotype solely by defective GH/IGF-1 signaling. 
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Despite having high fat to body weight ratio and obesity after adulthood, GHR-KO mice show 
improved insulin sensitivity (Masternak et al., 2012), which demonstrates that high fat 
deposition alone does not cause insulin resistance. 
1.1.4.2 Growth hormone-releasing hormone knockout mice 
The latest mouse model genetically modified to disrupt GH signaling was introduced in 2013 (L. 
Y. Sun et al., 2013). Growth hormone releasing hormone knock-out (GHRH-KO) mice are 
defective in GH/IGF-1 signaling and live more than 40% longer than normal siblings. They have 
reduced body weight and lower circulating IGF-1 levels, similar to other mouse models of 
disrupted GH signaling. Interestingly, despite exhibiting elevated adiponectin levels, increased 
insulin sensitivity, and lower plasma glucose concentration under fasting conditions, they have 
higher subcutaneous fat (both sexes) and perirenal fat (males only) to body weight ratio (L. Y. 
Sun et al., 2013).  
1.1.4.3 Pregnancy-associated plasma protein-A knockout mice 
Another model of disrupted GH/IGF-1 signaling is the pregnancy-associated plasma protein A 
knock-out (PAPPA KO) mouse (Conover & Bale, 2007). The mechanism and location of GH/IGF-1 
disruption in PAPPA-KO mice differs from previous models which are defective either in 
secretion or recognition of GH. The Pappa gene encodes a zinc metalloproteinase which 
degrades certain proteins that inhibit IGF-1 signal transduction by binding to IGF-1. Degradation 
of these inhibitory factors facilitates IGF signaling. So, PAPPA knock-out results in the inhibition 
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of IGF-1 signal transduction, without directly altering the expression of IGF-1 or IGF-1 receptors. 
As opposed to GH or IGF-1, PAPPA acts locally to enhance IGF activity on the microenvironment 
it is expressed in. 
PAPPA-KO mice live around 30% longer than normal controls (Conover et al., 2010). They 
exhibit normal serum levels of glucose, insulin, GH, and IGF-1. In old animals (23-38-month-old), 
tumor incidence and size are lower in PAPPA-KO mice (Conover & Bale, 2007). 
1.1.5 Theories of longevity 
Comparisons of young to old mice have revealed many effects of aging, but given little insight 
into factors that cause aging or regulate its rate. An alternative approach utilizes long-lived 
mouse models to identify characteristics found in these mice but not in their normal 
counterparts. This approach became possible only after the establishment of long-lived mutant 
mice strains and generation of genetically modified mice with extended lifespan.  
1.1.5.1 GH and IGF-1 signaling pathways 
Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) promote organismal growth. 
GH/IGF-1 secretion decays gradually after adulthood, and partial reversal of this decay in 
elderly by recombinant human GH treatment has been shown to induce some positive effects 
on lean body mass, adipose mass, and skin thickness (Rudman et al., 1990), and initially led to 
consideration of GH and IGF-1 as candidate pro-longevity agents. Indeed, the alterations in 
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GH/IGF-1 pathway seem to be important for longevity, but not in the expected direction. Snell 
(Pit1dw/dw), Ames (Prop1dw/dw), Ghrhrlit/lit, growth hormone receptor knock-out (GHR-KO), and 
growth hormone releasing-hormone knock-out (GHRH-KO) mice all have disrupted GH/IGF-1 
signaling, and they exhibit lifespan extension (Coschigano et al., 2003; Flurkey et al., 2001; Sun 
et al., 2013).  
Consistent with the idea that IGF-1 deficiency might lead to slower aging, mice lacking one copy 
of the IGF-1 receptor (Igf-1r+/- mice) live longer than wildtype controls (Holzenberger et al., 
2003) with an average lifespan increase of ~30% in females and ~15% in males. Adult body size 
is 6-8% smaller than normal mice. IGF-1 expression in Igf-1r+/- mice as measured by ligand 
binding assay is around 50% less than wildtype levels. Blood IGF-1 levels are 25-40% higher, 
probably due to decreased levels of negative feedback signaling through IGF-1R. Unlike Ghr 
deletion (Ghr-/-), which extends lifespan, homozygous deletion of Igf-1r (Igf-1r-/-) is lethal. 
The negative relationship between IGF-1 signaling and lifespan is not limited to mice. Mutations 
in the gene expressing IGF-1 receptor homolog DAF-2 in C. elegans result in increased lifespan 
and a delay in aging phenotype (Kenyon, Chang, Gensch, Rudner, & Tabtiang, 1993). Mutations 
that lead to GH/IGF-1 deficiencies and dwarfism have also been documented in humans.  
GHRHR mutations in humans. A small population of ~100 people in Itabaianinha, Brazil carry a 
homozygous point mutation on GHRHR gene. Similar to Ghrhrlit/lit mice, affected people show 
GH/IGF-1 deficiency, have small body stature with adult heights in the range of 105-135 cm, 
and are fertile despite delayed onset of puberty (Salvatori et al., 1999). An analysis of limited 
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data on small number of subjects suggests no effect of lifespan, however, compared to 
unaffected heterozygous siblings, the frequency of deaths before the age of 20 is higher in 
affected females (Aguiar-Oliveira et al., 2010). Another cohort of 18 people with homozygous 
GHRHR mutation exhibiting dwarf phenotype is documented in Sindh, Pakistan. Emergence of 
affected population in this group is very recent. The oldest individual was 27 when the 
population was studied, so no lifespan data is available. Time of puberty was documented only 
in males, who show with 2-3 years delay in onset. However, no unusual pathology or early 
death is noted, and affected individuals present in good health and with normal intelligence 
(Maheshwari, Silverman, Dupuis, & Baumann, 1998).  
GHR mutations in humans – Laron syndrome (LS). Laron syndrome is characterized by deficient 
GH signaling accompanied by high blood GH levels reflecting GH insensitivity (Laron, 2004). It is 
caused by various GHR mutations, including exon deletions and point mutations. Two groups of 
affected people, a ~60 patient cohort in Israel and a ~90 patient cohort from Ecuador, are 
documented. Adult height is in the range of 108-142 cm. No systematic analysis of longevity in 
either cohort is available since both populations are relatively young and some of the affected 
individuals receive replacement therapy with recombinant biosynthetic IGF-1. Nevertheless, 
Laron comments that LS patients live a long life and both cohorts include individuals at their 70s 
(Laron, 2004).  
◦◦◦ 
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Expression levels of Pgc-1α (“Peroxisome proliferator-activated receptor gamma coactivator 1-
alpha”; regulator of mitochondrial biogenesis. See section 1.2.5) are found to be elevated in 
epididymal adipose tissue (Masternak et al., 2012), skeletal muscle (assessed in females), and 
kidney (assessed in males) of GHR-KO mice, as well as in epididymal adipose tissue of Ames 
mice (assessed in males) (Menon et al., 2014), suggesting that diminished GH/IGF1 signaling 
may result in upregulation of the mitochondrial biogenesis pathway. PGC-1α protein expression 
data is available only for kidneys of GHR-KO males, and it is found to be ~50% higher (Gesing, 
Bartke, Wang, Karbownik-Lewinska, & Masternak, 2011). Assessment of PGC-1α levels in other 
tissues in both sexes, as well as TFAM (“Mitochondrial transcription factor A”; see section 1.2.5) 
expression, is needed to gain a better understanding on possible changes in mitochondrial 
biogenesis pathway in these mice. It would also be of interest to see whether Snell mice, which 
are also deficient in GH/IGF-1 signaling, have elevated expression genes involved in 
mitochondrial biogenesis. 
While GH/IGF-1 signaling has been the main focus of attention, other hormonal pathways may 
also contribute to life extension in long-lived mutant mice. Supporting this possibility, growth 
hormone treatment before adulthood (between 4 and 15 weeks of age) does not diminish 
lifespan extension in Snell mice unless it is followed by lifelong thyroxin treatment (Vergara, 
Smith-Wheelock, Harper, Sigler, & Miller, 2004). Snell mice receiving additional thyroxin after 
15 months of age show 17% decrease in mean lifespan, suggesting a possible prolongevity 
effect of thyroxin deficiency in Snell mice. 
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Although the specific mutations resulting in lifespan extension in Snell dwarf mice and in other 
long-lived mutant mice are well described and have major effects on GH/IGF1 signaling, how 
these alterations result in prolonged lifespan remains elusive. Modifications in a variety of 
cellular pathways have been proposed to play a causative role in longevity of these GH/IGF1 
deficient mice, including diminished mTOR signaling (Dominick et al., 2015), increased 
autophagy (M. Wang & Miller, 2012b), and elevated proteasome activity (Drake, Miller, Miller, 
& Hamilton, 2015; Pickering, Lehr, & Miller, 2015). 
1.1.5.2 mTOR as a regulator of cellular metabolism 
“Mechanistic target of rapamycin” (mTOR) is a serine/threonine kinase initially identified in 
yeast by its inhibition by rapamycin (Heitman, Movva, & Hall, 1991). It forms two protein 
complexes “mTOR complex 1” (mTORC1) and “mTOR complex 2” (mTORC2), and through their 
activity it can regulate basic cellular functions including growth, maintenance, and translation. 
Given its involvement in such fundamental pathways, it is not surprising that mTOR activity is 
altered in several models of longevity. A brief summary of mTOR complexes, regulation of 
mTOR by GH/IGF-1 and intracellular signals, and their implications in lifespan extension is given 
in this section.  
mTORC1 is composed of mTOR, regulatory-associated protein of mTOR (RAPTOR), and some 
other putative protein components (D. H. Kim et al., 2002). mTORC1 regulates protein synthesis 
according to extracellular signals from insulin and growth factors and intracellular signals 
reflecting nutrient, energy, and redox state of the cell. mTORC2 is primarily composed of mTOR 
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and rapamycin-insensitive companion of mTOR (RICTOR). Both mTORC1 and mTORC2 seem to 
be essential for mammalian development since knock-outs of their corresponding components 
Raptor and Rictor result in death at the embryonic stage.  
Insulin and IGF-1 are well-established extracellular regulators of mTORC1. Insulin/IGF-1 
signaling promotes mTORC1 activity through a signal transduction pathway involving AKT 
(“Protein kinase B”; also PKB). A brief summary of the mechanism of AKT-mediated mTOR 
regulation should be provided to understand how mutations in this pathway and deficient 
GH/IGF1 signaling affect mTOR activity and lifespan. 
RHEB (“Ras homolog enriched in brain”) is a GTP-binding protein, which, in its GTP-bound state 
(RHEB-GTP) activates mTORC1. TSC2 (“Tuberous sclerosis complex 2; tuberin”, a GTPase 
activating protein) forms a complex (TSC) with TSC1 to hydrolyze GTP of the active Rheb-GTP 
complex and deactivate it, resulting in mTORC1 inhibition (Garami et al., 2003). Extracellular 
insulin, IGF-1, and IGF-2 are recognized by insulin receptor, IGF-1 receptor, and insulin/IGF1 
receptor complexes. Their binding activates a signal cascade through PI3K (“Phosphoinositide 3-
kinase”) and PDK (“PI3-dependent kinase”), resulting in T308 phosphorylation of AKT (Garami 
et al., 2003). By inhibiting TSC formation, AKT relieves Rheb from deactivating activity of TCS, 
and promotes mTORC1 signaling.  
AMP-activated protein kinase (AMPK) is an intracellular regulator of mTORC1 activity. AMPK is 
activated when the cellular AMP:ATP ratio increases, and it promotes catabolic metabolism to 
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increase cellular ATP levels. AMPK inhibits mTORC1 by stimulating TCS activity and also by 
phosphorylating Raptor (Gwinn et al., 2008).  
Inhibition of mTORC1/2 signaling by genetic interventions or pharmacological approaches 
results in prolonged lifespan. The first study indicating a role for mTOR in longevity was in yeast, 
where deletion of sch9 (yeast ortholog of S6K downstream of mTORC1), led to lifespan 
extension in S. cerevisiae (Fabrizio et al., 2001). Deficient expression of the Raptor homolog daf-
15, mTOR homolog let-363 (K. Jia, Chen, & Riddle, 2004), or the Rictor homolog rict-1 (Soukas, 
Kane, Carr, Melo, & Ruvkun, 2009) extends lifespan in C. elegans. Downregulation of mTOR 
signaling by overexpression of either tsc1 or tsc2 in D. melanogaster also increases lifespan 
(Kapahi et al., 2004).  
In mice, genetic modifications which disrupt mTOR signaling pathways, including deletion of 
downstream S6k1 (females only)(Selman et al., 2009) or upstream Irs1 (insulin receptor 
substrate 1) (Selman, Partridge, & Withers, 2011), heterozygous deletion of Igf1r (females only) 
(Bokov et al., 2011) or Akt1 (Nojima et al., 2013), and partial disruption of mTOR (J. J. Wu et al., 
2013), extend lifespan. Mouse lifespan can also be extended by pharmacological inhibition of 
mTOR by rapamycin treatment, even by rapamycin treatment late in life (Harrison, Strong, 
Fernandez, & Miller, 2009).  
Rapamycin, isolated in 1972 from the bacterium Streptomyces hygroscopicus as an antifungal 
metabolite (Sehgal, Baker, & Vezina, 1975; Vezina, Kudelski, & Sehgal, 1975), is an FDA-
approved compound for its use as an immunosuppressive and anti-cancer drug. Its prolongevity 
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effect is a more recent discovery and has been documented in S. cerevisiae (Powers, 
Kaeberlein, Caldwell, Kennedy, & Fields, 2006), C. elegans (Robida-Stubbs et al., 2012), D. 
melanogaster (Bjedov et al., 2010), and mice (Miller et al., 2011).  
Supporting a prolongevity role for decreased mTOR signaling, long-lived Ames mice show 
downregulation in the PI3K/mTOR/Akt signal transduction pathway (Sharp & Bartke, 2005), 
presumably due to decreased IGF-1 signaling in dwarf mice. Reduced mTOR activity is also 
indicated in lifespan extension induced by calorie restriction. How reduced mTOR activity 
increases lifespan is not known. 
1.1.5.3 Improved stress response  
Increased ability to function under stress and to survive suboptimal conditions emerges as a 
common feature of long-lived nematodes, insects, and cells from long-lived mammals.  
Long-lived C. elegans strains with mutations affecting insulin/IGF-1 signaling (age-1, daf-2, daf-
23 mutants) or mitochondrial metabolism (clk1 mutant) show increased resistance to UV 
radiation (Murakami & Johnson, 1996). Compared to wildtype worms, age-1 mutants also have 
higher survival rates after heat exposure (Lithgow, White, Hinerfeld, & Johnson, 1994) and after 
hydrogen peroxide treatment (Larsen, 1993). In addition, both age-1 and daf-2 mutants are 
better protected from death induced by cadmium and copper exposure (Barsyte, Lovejoy, & 
Lithgow, 2001). 
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In comparison to their normal counterparts, primary fibroblasts from long-lived Snell and Ames 
mice survive higher doses of UV radiation, hydrogen peroxide, paraquat, and cadmium 
exposure (Murakami, Salmon, & Miller, 2003; Salmon et al., 2005). Fibroblasts from GHR-KO 
mice show increased resistance to treatment with UV radiation, hydrogen peroxide, and 
paraquat, but not cadmium (Salmon et al., 2005). An indirect indication of protection from 
oxidative damage is also noted in Laron syndrome patients. Pre-exposure of human epithelial 
cells to serum from LS patients, but not from their unaffected siblings, results in increased 
protection from to H2O2-induced DNA breaks, but it also increases apoptosis (Guevara-Aguirre 
et al., 2011), which may be a protective mechanism by containing the damage and by 
preventing further mutations.  
Mice deficient in IGF-1 signaling (Igf-1r+/- mice), which also live longer, survive intraperitoneal 
paraquat injection better than normal mice (Holzenberger et al., 2003). Also, as reported for 
other long-lived mutants, ex-vivo analyses of primary cells isolated from IGF-1 deficient mice 
indicate increased resistance to hydrogen peroxide-induced cell death (Holzenberger et al., 
2003). As a side note, this study evaluates hydrogen peroxide resistance as the ratio of surviving 
cells after exposure to a certain dose of peroxide. This approach differs from widely used 
“lethal dose 50 (LD50)” analysis wherein the cells are exposed to a range of different doses to 
calculate the dose that kills 50% percent of the initial population. 
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1.2  Mitochondria 
Mitochondria were first recognized as distinct organelles in 1890 by Altman who observed 
these intracellular structures and called them "Bioblasts" (Altmann, 1890). He thought that 
these structures comprised the morphological unit of living matter ("Im Bioblast scheint jene 
morphologische Einheit der lebenden Ma terie gefunden zu sein."). The use of the name 
"mitochondrion" started around 1900 due to the resemblance of these structures to threads 
("mitos" in Greek) made of small compact particles ("chondro" in Greek) during 
spermatogenesis (Ernster & Schatz, 1981)(Pagliarini & Rutter, 2013). For the next fifty years 
following their discovery, mitochondria were recognized by their specific staining with the 
redox dye Janus Green B, with no mechanistic understanding of the specificity of this dye for 
mitochondria.  
Mitochondrial research during the first half of the 20th century resulted in important 
developments around 1950, mostly stemming from the successful isolation of mitochondria by 
fractionation and the development of electron microscopy. 
1.2.1 Mitochondrial DNA 
Mitochondria contain their own DNA called "mitochondrial DNA" (mtDNA) (Schatz, 
Haslbrunner, & Tuppy, 1964). Depending on the species and tissue type, each cell may have 
hundreds to thousands of mtDNA molecules. mtDNA is a circular double-stranded DNA 
comprised of 16-17K base pairs in mammals; 16295 base pairs in mice (Bibb, Van Etten, Wright, 
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Walberg, & Clayton, 1981) and 16569 base pairs in humans (Anderson et al., 1981). It encodes 
13 peptides, which are subunits of electron transport chain (ETC) complexes, 2 mitochondrial 
rRNAs, 22 mitochondrial tRNAs, and some putative peptides with elusive expression and 
function including Humanin and MOTS-c (Shokolenko & Alexeyev, 2017) (Table 1).  
The mitochondrial genome is mostly comprised of coding sequences as opposed to intron-rich 
nuclear genome (Gustafsson, Falkenberg, & Larsson, 2016). Mitochondrial DNA is so compact 
that it hosts rare instances of “overlapping gene” sequences in humans. ATP6 and ATP8, which 
encode subunits of ATP Synthase (ETC complex V), as well as ND4 and ND4L, which encode 
subunits of NADH-ubiquinone oxidoreductase (ETC complex I), share overlapping nucleotide 
sequence encoded in alternate reading frames producing distinct peptide sequences. Strands of 
mtDNA are named according to their relative guanine content as heavy (contains more 
guanine) and light strands.  
Mitochondria carry out vital cellular functions including ATP production by oxidative 
phosphorylation and heme biosynthesis. They also regulate intracellular calcium concentration, 
function in thermogenesis, and can initiate apoptosis by cytochrome c release. Production of 
reactive oxygen species (ROS) is also listed among the functions of mitochondria by some 
researchers, although ROS can also be considered a byproduct of metabolism as will be 
discussed later. 
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Gene product  Component of Mouse gene mtDNA strand 
NADH dehydrogenase 1 (ND1) ETC complex I Nd1 Heavy 
ND2 ETC complex I Nd2 Heavy 
ND3 ETC complex I Nd3 Heavy 
ND4 ETC complex I Nd4 Heavy 
ND4L ETC complex I Nd4l Heavy 
ND5 ETC complex I Nd5 Heavy 
ND6 ETC complex I Nd6 Light 
Cytochrome b ETC complex III Cytb Heavy 
Cytochrome c oxidase 1 (COXI) ETC complex IV CoxI or co1 Heavy 
COX2 ETC complex IV Cox2 or co2 Heavy 
COX3 ETC complex IV Cox3 or co3 Heavy 
ATP6 ATP Synthase 
(ETC complex V) 
Atp6 Heavy 
ATP8 ATP Synthase 
(ETC complex V) 
Atp8 Heavy 
Ribosomal RNA  
small subunit 12S 
Mitochondrial ribosome Mt-rnr1 Heavy 
Ribosomal RNA 
large subunit 16S 
Mitochondrial ribosome Mt-rnr2 Heavy 
22 Transfer RNAs (tRNAs) Mitochondrial translation 
machinery 
Mt-trn[*] 
[*] = A, R, N, 
D, C, E, Q, G, 
H, I, L1, L2, K, 
M, F, P, S1, S2, 
T, W, Y, or V. 
Heavy (14) 
and 
Light (8) 
Table 1 Peptides and RNAs encoded in mtDNA 
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1.2.2 Oxidative phosphorylation 
By mid-20th century, it was known that ATP production by aerobic respiration took place in the 
mitochondria (Kennedy & Lehninger, 1949). However, the development of a viable theory for 
the underlying mechanism required diligent research for the next 20 years.   
In 1961, Peter Mitchell proposed a model to explain coupling of electron transfer and 
phosphorylation (Mitchell, 1961). The “chemiosmotic hypothesis” is explained in great detail in 
Mitchell’s brilliantly written book “Chemiosmotic coupling and energy transduction” (Mitchell, 
1968). Briefly, he proposed that oxido-reduction reactions carried out by ETC complexes create 
a protein gradient through the inner mitochondrial membrane by moving hydrogen ions 
(protons) from matrix to the intermembrane space (IMS). Once the proton gradient is present, 
a proton-translocating ATPase located on the inner membrane works in reverse direction to 
synthesize ATP from ADP and Pi using the energy generated by the flow of protons from the 
intermembrane space to the matrix. Mitchell’s model not only provided a mechanism for the 
conservation of energy generated in distinct steps, but also implied the presence of an ion-
impermeable inner membrane, which would explain the uncoupling effect of membrane-
permeabilizing agents. Most importantly, it elaborated a hitherto unknown biological 
mechanism for energy conversion and transduction where molecular concentration gradients 
(potential energy) between separated compartments are created and utilized to carry out a 
chemical reaction which is coupled to the controlled flow of molecules down the concentration 
gradient.  
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  Electron transfer  → Proton gradient  →  Phosphorylation  
  (chemical energy)   (potential energy)  (chemical energy) 
Oxidative respiration is carried out by electron transport chain (ETC) complexes located on the 
inner mitochondrial membrane: the proton gradient is generated by ETC complexes I-IV, while 
ATP synthesis by phosphorylation is performed by ATP synthase (also called “ETC complex V”), 
as discussed in the next section. 
1.2.3 Respiratory chain  
The respiratory chain, also named electron transport chain (ETC), comprises five multiple-
subunit protein complexes located in the inner mitochondrial membrane. Each complex, except 
complex II, is formed by coordinated assembly of nuclear-DNA-encoded and mitochondrial-
DNA-encoded peptides in a precise stoichiometry (Table 2).  
Complex Common name nDNA-encoded 
subunits 
mtDNA-encoded 
subunits 
Total 
I NADH-ubiquinone oxidoreductase 37  7  44 
II Succinate-ubiquinone 
oxidoreductase 
4  - 4 
III Ubiquinone-cytochrome c 
oxidoreductase 
10 1 11 
IV Cytochrome c oxidase 11 3 14 
V ATP synthase 12 2 14 
Total Electron transport chain 74 13 87 
Table 2 Electron transport chain complexes in mammalian mitochondria 
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ETC complex I is called NADH-ubiquinone oxidoreductase. In mammals, it is a ~1000 kDa, 44-
subunit protein complex. Seven core peptides, named ND1 to ND6 and ND4L, are encoded in 
the mtDNA. The remaining 37 peptides are encoded in the nDNA, translated in the cytosol, 
transported to the mitochondria, folded into their native structure in the mitochondrial matrix, 
and amalgamated with the mtDNA-encoded core peptides to form the complex I assembly. As 
will be explained later, the formation of ETC complexes comprised of peptides encoded both in 
the nuclear and the mitochondrial DNA requires strict regulation and communication between 
cellular and mitochondrial transcription. As the name implies, NADH-ubiquinone 
oxidoreductase oxidizes NADH and reduces ubiquinone (Q) with the overall reaction shown 
below: 
NADH + Q + 5H+ → NAD⁺ + QH2 + 4H⁺ 
Importantly, the five protons entering the reaction are taken from the matrix, and the four 
protons on the right-hand side of the reaction are released to the intermembrane space, 
resulting in the transfer of four protons from the matrix to the intermembrane space. The 
“pumping” of the protons through the inner membrane creates a proton gradient which is 
utilized to generate the electromotive force required for ATP production by complex V (ATP 
synthase). 
Complex I activity can be inhibited by multiple compounds including MPTP (1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine), phenoxan, piericidin A, annonin VI, amytal, and rotenone. Among 
27 
 
those, rotenone is regularly used in mitochondrial research, as it is used in this work for the 
analysis of individual components of oxygen consumption.  
◦ ◦ ◦ 
Complex II, succinate-ubiquinone oxidoreductase, is the smallest of the five complexes – it 
consists of four subunits. It also differs from other complexes in that it is not buried in the inner 
membrane but attached to the inner mitochondrial membrane on the matrix side through its 
interaction with the integral membrane proteins. In addition to the four subunits complex II 
also contains cofactors and metal ions. The largest peptide of the complex is covalently bound 
to a flavin to form flavoprotein subunit (Fp) (Walker & Singer, 1970). Another smaller subunit, 
called iron-protein subunit (Ip), contains nine iron atoms in three Fe-S centers. The Ip and Fp 
subunits together constitute the enzyme succinate dehydrogenase (SDH).  
Complex II is the only ETC complex that is composed of nuclear-DNA-encoded subunits with no 
contribution from mtDNA in mammals. As complex II oxidizes succinate to fumarate in the 
Krebs cycle, it reduces ubiquinone to QH2 in the ETC, linking the two pathways: 
Succinate + Q → Fumarate + QH2 
As in the case of complex I, inhibitors specific to complex II are utilized in biochemical analysis 
of the electron transport chain. The succinate analog malonate binds to complex II, competing 
with and inhibiting succinate binding, and is therefore utilized to block succinate : ubiquinone 
oxidoreductase activity.  
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◦ ◦ ◦ 
Complex III, ubiquinol-cytochrome c oxidoreductase, is also called “cytochrome c reductase” or 
“bc1 complex” referring to its components cytochrome b and cytochrome c1. It reduces 
cytochrome c and pumps 4 protons from matrix to IMS.  
QH2 + 2 Fe+3 cyt c + 2 H+(Matrix) →  Q + 2 Fe2+ cyt c + 4 H+(IMS)  
Complex III is composed of 11 peptides in mammals and 9 peptides in yeast. Only one of these 
peptides, cytochrome b, is encoded in the mtDNA. The remaining subunits are encoded in the 
nuclear DNA. 
Specific inhibition of complex III can be achieved by the antibiotic antimycin A. Assays of 
oxidative respiration make use of antimycin A to dissect mitochondrial versus cytosolic portions 
of total oxygen consumption. In our work, we use a modified protocol which includes inhibition 
of antimycin A-mediated inhibition of complex III to analyze oxidative respiration after 
mitochondrial stress exposure.  
◦ ◦ ◦ 
Complex IV, also referred as “cytochrome c oxidase”, catalyzes the overall reaction where O2 
consumption takes place and H2O is produced; molecular oxygen receives the electrons, 
cytochrome c is reoxidized, and 4 protons are pumped from the matrix to intermembrane 
space.  
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4 Fe2+ cyt c + 8 H+(Matrix) + O2 (Matrix) → 4 Fe3+ cyt c + 4 H+ (IMS) + 2 H2O(Matrix) 
The mammalian complex IV is composed of 13 protein subunits. In addition, it contains the two 
heme groups (heme a and a3), and three copper atoms (2 CuA and CuB) required for separation 
of the oxygen atoms in the O2 molecule to form H2O. The largest subunits, COXI, COXII, and 
COXIII are encoded in the mtDNA and synthesized in the mitochondrial matrix. The remaining 
ten subunits of the mammalian complex IV are COXIV, COXVa-b, COXVIa-c, COXVIIa-c, and 
COXVIII.  
Complex IV catalyzes a critical process where partially reduced oxygen may be released and 
produce the superoxide radical ▪O2-, which can lead to production of hydrogen peroxide (H2O2) 
or hydroxyl radical (▪OH). However, it is not clear whether mitochondrial reactive oxygen 
species are produced as a result of incomplete oxygen reduction in complex IV or generated 
independent of oxygen reduction reactions.  
◦ ◦ ◦ 
Complex V is the ATP synthase, and is considered part of the ETC complexes. In principle this 
perception is not correct since ATP synthase is not an electron transporter. It functions 
independent of the complexes I-IV by using the proton gradient generated by ETC complexes I-
IV as energy source to produce ATP. Complex V can be inhibited by oligomycin. Analysis of 
respiration rate when ATP synthase is blocked allows assessment of the amount of respiration 
directly utilized in ATP production.  
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1.2.4 Thermogenesis 
Brown fat utilizes the proton gradient created by mitochondrial respiration chain for a different 
purpose; it generates heat for non-shivering thermogenesis. Interestingly, this is achieved by a 
mechanism that counters ATP production. Initially it was believed that brown fat generated 
heat by rapid production and consumption of ATP. However, this idea conflicted with findings 
indicating the presence of low levels of ATP synthetase and the absence of electron-transport 
coupled phosphorylation in brown fat mitochondria (Lindberg, de Pierre, Rylander, & Afzelius, 
1967) despite the higher density of mitochondria present in this tissue. Analysis of 
mitochondria isolated from guinea pig brown adipose tissue led to the discovered that a 32 KDa 
ion uniport protein localized to the inner mitochondrial membrane acting as mitochondrial 
uncoupler was responsible for the heat generation during thermodynamic adaptation (Heaton, 
Wagenvoord, Kemp, & Nicholls, 1978). The uniporter protein was purified (Lin, Hackenberg, & 
Klingenberg, 1980), sequenced (Aquila, Misra, Eulitz, & Klingenberg, 1982), and a decade after 
its association with thermogenesis, it was cloned and named “Uncoupler Protein (UCP)”. Since 
the identification of its homologue “Uncoupler Protein 2 (UCP2)” in 1997 (Fleury et al., 1997; 
Gimeno et al., 1997), it has been known as “Uncoupler Protein 1 (UCP1)” or “Thermogenin”.  
Thermogenesis demonstrates how mitochondrial protein gradient can be regulated according 
to tissues-specific functions. While it is utilized for ATP synthesis in other tissues, in brown fat 
the protons are allowed to flow though the inner membrane in order to produce heat by 
burning maximum amount of oxygen.  
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1.2.5 Mitochondrial biogenesis 
Mitochondria are produced by growth and division of pre-existing mitochondria as opposed to 
de novo generation (Schatz et al., 1964). Mitochondria have their own transcription machinery, 
which is distinct from its counterparts residing in the nucleus as well as in the bacteria. 
Nevertheless, mitochondrial biogenesis is not autonomous but regulated by nuclear-DNA-
encoded proteins. In vitro, efficient mitochondrial transcription requires only three proteins 
(Shutt, Lodeiro, Cotney, Cameron, & Shadel, 2010). Mitochondrial RNA polymerase (POLRMT) is 
a single subunit protein homologous to RNA polymerase found in T3 and T7 bacteriophages 
(Masters, Stohl, & Clayton, 1987). While no transcription factor is necessary for phage 
polymerase activity, POLRMT requires mitochondrial transcription factors A (TFAM) and B2 
(TFB2M).  
The mitochondrial transcription process is not fully understood, and less is known about 
mitochondrial translation events. So far, in vitro reconstitution of mitochondrial translation has 
not been achieved.  
1.2.5.1 Mitochondrial transcription factor A 
The first component of the mitochondrial transcription machinery to be purified was 
mitochondrial transcription factor A (TFAM), initially referred as “mitochondrial transcription 
factor 1” (Fisher & Clayton, 1988). It contains a matrix targeting sequence (MTS) and two HMG 
32 
 
DNA binding domains (HMG1 and HMG2), which can bind the DNA in minor groove to bend and 
unwind it. In contrast to nuclear transcription factors, TFAM is not gene-specific. 
TFAM binds to mtDNA at 10-40 nucleotides upstream of promoter regions (Fisher, Topper, & 
Clayton, 1987) and bends the mtDNA (Ngo, Kaiser, & Chan, 2011; Rubio-Cosials et al., 2011). 
DNA-bound TFAM recruits POLRMT to form pre-initiation complex (Morozov et al., 2014), 
which recruits TFB2M to initiate translation (Sologub, Litonin, Anikin, Mustaev, & Temiakov, 
2009). Mitochondrial transcription produces polycistronic transcripts which are spliced into 
individual mRNAs. Mitochondrial transcripts have no 5’methyladenosine caps and very short 
poly(A) regions – if any.  
Mice heterozygous for Tfam gene disruption (Tfam+/-) are viable but show respiration chain 
deficiency and low mtDNA content, whereas TFAM knock-out (Tfam-/-) mice die before 
embryonic day 11 (Larsson et al., 1998). Consistent with its function in mitochondrial 
transcription and mtDNA replication, deletion of Tfam in cardiomyocytes (H. Li et al., 2000), 
skeletal muscle (Wredenberg et al., 2002), pancreatic beta-cells (Silva et al., 2000), or forebrain 
neurons (Sorensen et al., 2001) results in depletion of mitochondrial transcripts and electron 
transport chain proteins in corresponding tissues. Cardiac-specific Tfam knock-out mice show 
severe defects in heart starting at 2 weeks of age including mtDNA depletion, impaired ETC 
function, reduced ATP levels, and progressive cardiomyopathy (Hansson et al., 2004).  
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1.2.5.2 Peroxisome proliferator-activated receptor gamma coactivator 1 alpha 
Peroxisome proliferator-activated receptor gamma (PPARγ) coactivator 1-alpha (PGC-1α) was 
isolated from brown fat cells through its interaction with PPARγ (Puigserver et al., 1998). PGC-
1α does not directly bind to DNA, but it binds to various transcription factors and activates 
them. In addition to PPARγ, it interacts with thyroid hormone receptor β (TRβ), retinoic acid 
receptor alpha (RARα), and estrogen receptor alpha (ERα). 
As soon as Pgc-1α had been isolated, it was observed that Pgc-1α induction was accompanied 
by elevated mtDNA abundance and upregulation of mtDNA-encoded genes including subunits 
of cytochrome c oxidase and ATPase, providing an early sign for its role in mitochondrial 
biogenesis (Puigserver et al., 1998). Follow-up studies established that, PGC-1α directly induces 
mitochondrial biogenesis by co-activating nuclear respiratory factors to upregulate TFAM which 
regulates both mtDNA replication and mitochondrial transcription (Z. Wu et al., 1999).  
Ectopic Pgc-1α expression increases mitochondrial biogenesis and oxidative respiration in 
skeletal muscle cells and in cardiac muscle cells (Lehman et al., 2000). In vivo, Pgc-1α 
overexpression in type II skeletal muscle fibers increases mitochondrial mass, and induces fiber 
type switch from glycolytic type IIb fibers to more oxidative type I and IIa fibers (J. Lin et al., 
2002). Similarly, cardiac-specific Pgc-1α overexpression induces extensive mitochondrial 
proliferation in heart disturbing sarcomere structure (Lehman et al., 2000). Effects of artificially 
upregulated Pgc-1α expression suggest that Pgc-1α can induce mitochondrial biogenesis and 
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increase oxidative respiration both in cell culture and in vivo - at least in skeletal and heart 
muscle.  
In addition to transgenic mice, studies on Pgc-1α-deficient mice have provided key findings on 
the critical role of Pgc-1α on mitochondrial biogenesis and function. Somewhat unexpectedly, 
by 3 months of age, PGC-1α KO mice show no structural defects in heart or in skeletal muscle 
fibers, two tissues with high energy demand. Mitochondrial content in heart is also comparable 
between Pgc-1α-/- and normal mice. At first, the healthy looking phenotype of 3-month old 
PGC-1α KO mice may seem to be in contradiction with proposed function of Pgc-1α in 
mitochondrial biogenesis. In fact, it underlies two important qualities of mitochondrial biology 
highly relevant to our work:  
(i) Comparable mitochondrial content does not imply comparable mitochondrial function, i.e. in 
the case of mitochondria, functionality cannot be deduced from abundance.  
Although they exhibit no abnormality in mitochondrial content or morphology, both heart and 
skeletal muscle of PGC-1α KO mice have reduced expression of ETC complex subunits, including 
those of ATP synthase and cytochrome c oxidase which are required for oxidative respiration 
(Arany et al., 2005). In addition, expression of Tfam, which is required for mitochondrial 
transcription, is also reduced in PGC-1α deficient mice. Consistent with reduced expression of 
respiration chain components, ATP content in heart of PGC-1α KO mice is 20% lower than 
normal despite comparable mitochondrial content. Of note, 20% reduction in cardiac ATP 
content is of physiologic importance since ~30% decrease in ATP content is associated with 
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terminal heart failure (Bashore, Magorien, Letterio, Shaffer, & Unverferth, 1987; Starling, 
Hammer, & Altschuld, 1998). PGC-1α KO mice also show defective cardiac function with more 
than 50% decrease in contractile performance (Arany et al., 2005).  
(ii) Defects in mitochondrial biology become more apparent as the organism gets older due to 
cumulative effects of mitochondrial damage accumulation and impaired mitochondrial stress 
response. 
No structural abnormality or morphological signs of cardiac defects are observed in Pgc-1α-/- 
mice at 3 months of age. However, as early as 8 months of age, which corresponds to 
adulthood period, symptoms of cardiac dysfunction become apparent (Arany et al., 2005). Left 
ventricular chamber size gets more dilated, and the contraction-induced change in internal 
diameter gets smaller, indicating impaired cardiac contraction. Also, upregulated expression of 
certain genes, which is used as a molecular marker of cardiac stress, can be detected in hearts 
of adult Pgc-1α deficient mice (Arany et al., 2005). Development of cardiac dysfunction only 
after adulthood exemplifies the aging-associated gradual development of mitochondrial 
pathologies caused by mitochondrial maintenance defects.  
In mice, Pgc-1α mRNA can be detected by northern blot analysis in brown fat, heart, kidney, 
and brain, but not in white fat, lung, skeletal muscle, liver, testes, or spleen (Puigserver et al., 
1998). Upon cold exposure (4 °C for 12 hours), Pgc-1α expression is robustly induced in brown 
fat and skeletal muscle, while heart, kidney, white fat, and liver are not affected.  
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1.2.6 Mitochondrial stress response 
1.2.6.1 Cellular protein homeostasis  
Proteostasis is an auto-regulation process through which a biological system reacts to 
competing intrinsic factors and environmental changes to keep the proteome in a stable, 
functional state. Cellular mechanisms regulating proteostasis can be summarized in three main 
groups: protein biogenesis, folding and conformational maintenance, and degradation. It is 
estimated that, in mammalian cells, there are around 400 proteins functioning in protein 
biogenesis, 300 in folding and maintenance, and 700 in degradation, some falling in more than 
one group (Y. E. Kim, Hipp, Bracher, Hayer-Hartl, & Hartl, 2013). 
Protein folding can be defined as the process through which a linear polypeptide reaches its 
well-defined three-dimensional conformation, forming the functional protein (Hartl, 1996). In 
the 1950s, multiple researchers reported that they were able to observe denatured proteins 
fold into their native state spontaneously in vitro (Anfinsen, 1973). These observations led to 
the "thermodynamic hypothesis" which stated that the native three dimensional state of the 
protein in physiological environment has lower entropy, so a polypeptide chain folds into the 
correct conformation spontaneously, and the native conformation of a protein is totally 
determined by its amino acid sequence (R. J. Ellis & Minton, 2006). As the thermodynamic 
hypothesis gained support, the general belief in 1970s was that folding of proteins and their 
assembly into oligomers could take place in cells in vivo without a need for molecular catalysts 
or energy consumption (Anfinsen, 1973).  
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This view started to be challenged by the new findings in the 1990s (Hartl, 1996). Cytosol, as 
opposed to the conditions set in vitro, is a crowded medium with an estimated macromolecule 
density of 300 mg/ml (R. J. Ellis & Minton, 2006). Newly synthesized peptides are prone to 
interactions with proteins and other molecules present in the cytosol which can interfere with 
their folding. Moreover, some peptides should be maintained in an unfolded state until they 
are transported to a specific location in the cell, such as mitochondria, where they are folded 
into their functional structure. Premature folding or misfolding during transport would render 
the peptides unsuitable to pass through membranes enclosing the target compartment. Proper 
translocation and folding of many proteins require regulated interactions with specific proteins 
called molecular chaperons.  
1.2.6.1.1 Chaperons 
The term "molecular chaperons" was proposed in 1987 by John Ellis to describe "a class of 
cellular proteins whose function is to ensure that the folding of certain other polypeptide 
chains and their assembly into oligomeric structures occur correctly" (J. Ellis, 1987). The 
existence of such a group of proteins was suggested a year earlier by Hugh Pelham, who, 
commenting on the presence of proteins related to Hsp70 and Hsp90 in both ER and cytoplasm 
of unstressed cells, speculated that they may play a role in protein folding and assembly 
occurring in both cellular compartments (Pelham, 1986). Incorporating our current 
understanding in Ellis's initial description, molecular chaperons can be described as proteins 
that interact with nascent peptides and with structurally unstable proteins to prevent their 
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misfolding, maintain them in an unfolded state during transportation, help them fold into 
native protein structure and assemble into oligomers, and facilitate their degradation (Hartl, 
1996; Hendrick & Hartl, 1993; Y. E. Kim et al., 2013). 
Most of the chaperons are "heat shock proteins" (HSPs). They were named HSPs because either 
(i) their expression was found to be upregulated in response to heat stress, or (ii) they share 
homolog sequences with other HSPs. HSPs are generally considered as stress-response 
proteins, but this categorization may be misleading. Although some of them are upregulated in 
response to stress (such as heat), many are not. Most are essential for cell function and 
indispensable under normal growth conditions. In fact, by 1996, years after their role in protein 
folding was established, it was not known whether Hsp70s had any protective function under 
stress conditions, including exposure to high temperature (Hartl, 1996). Accordingly, HSPs can 
be described as molecular chaperons which interact with structurally unstable peptides for 
their folding, assembly, transport, or degradation (Hendrick & Hartl, 1993) – with no 
requirement of heat-inducibility. 
There are two essential qualities of molecular chaperons involved in protein folding: (i) 
reusability; they do not take part in the final assembly. (ii) unspecificity; they do not carry any 
steric information for any specific protein.  
Chaperons are historically named according to their molecular weight: Hsp40s, Hsp60s, Hsp70s, 
Hsp90s, Hsp100s, and small Hsps, independent of their function or cellular localization. Heat 
shock protein 70 family proteins (Hsp70s), partnering with Hsp40s, bind to nascent and newly 
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translated polypeptide chains, maintain them in an unfolded soluble state, and release them 
still in unfolded conformation (Hartl, 1996). The Hsp70/Hsp40 complex requires ATP to perform 
its function.  
1.2.6.1.2 Chaperonins  
Chaperonins are multi-subunit double-ring protein complexes that form cavities to provide 
isolated spaces for proper folding of peptides into their 3D structure. In contrast to chaperons 
which release the peptides in unfolded state, chaperonins release peptides in folded tertiary 
conformation (Hartl, 1996). Chaperonins use an ATP-dependent mechanism to facilitate folding 
of the substrate proteins. The HSP60/HSP10 chaperonin is the key component of mitochondrial 
stress response, which is discussed next.  
1.2.6.2 A mitochondria-specific stress response 
A mitochondria specific stress response was first described in mammalian cells by Martinus et 
al. in 1996 (Martinus et al., 1996). By growing rat hepatoma cells in media containing ethidium 
bromide (EtBr) for 10 generations, the Hoogenraad group generated “ρ0 cells”, which means 
cells devoid of mitochondria DNA. Cells lacking mtDNA cannot synthesize the 13 peptides 
encoded in the mitochondrial genome, hence cannot perform oxidative respiration. Once 
mtDNA depletion is achieved, ρ0 cells are cultured in EtBr-free media supplemented with 
pyruvate and uridine. Cells devoid of mtDNA can be propagated at least a year and show 
growth characteristics similar to those of normal cells.  
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Although they lack mtDNA encoded ETC subunits, ρo cells still express ETC subunits encoded in 
the nuclear genome. Under these conditions, the mitochondria not only have impaired 
respiration but also accumulate unassembled nuclear-encoded ETC subunits which are prone to 
unfolding and aggregation, and induce a proteostatic stress load specifically in the 
mitochondria. It is found that the mitochondrial stress load in ρo cells induces a corresponding 
stress response specific for mitochondria, an organelle-specific protective mechanism similar to 
the previously discovered endoplasmic reticulum (ER)-specific unfolded protein response 
(UPRER). ρo cells show 2.5-fold higher protein levels of HSP60 and HSP10, which form the 
mitochondrial HSP60/HSP10 chaperonin. Protein levels of mitochondrial chaperon mtHSP70, 
constitutively expressed cytosolic chaperon HSP73, and stress-inducible cytosolic chaperon 
HSP72 are not altered, demonstrating that (i) not all mitochondrial chaperons and (ii) not all 
stress-inducible chaperons are upregulated in ρo cells. These observations indicate that 
HSP60/HSP10 upregulation is a major component of the mitochondrial stress response (MSR), 
which is lately referred as “mitochondrial unfolded protein response” (mtUPR; occasionally 
abbreviated UPRmt).  
Another study in COS-7 cells (a cell line derived from monkey kidney cells) showed that ectopic 
expression of truncated form of mitochondrial protein ornithine transcarbamylase (OTCΔ), 
which forms insoluble aggregates in the mitochondrial matrix, induces transcriptional 
upregulation of mitochondrial chaperonin components Hsp60 and Hsp10 (Zhao et al., 2002). 
Upregulation of HSP60 and HSP10 protein levels, previously reported in ρo cells, is also 
detected. In addition, an increase in transcript levels of mtDnaJ, Clpp, and Lonp1 is detected 
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upon ΔOTC expression, while transcript levels of mitochondrial chaperon mtHsp70, cytoplasmic 
chaperons Hsp72, Hsp73, and ER chaperon Bip are not affected.  
In worms, RNAi-mediated silencing of almost any protein which either takes part in the 
assembly of ETC complexes or functions in mitochondrial protein synthesis results in mtUPR 
induction (Yoneda et al., 2004). Loss of the mitochondrial protein gradient (ΔΨ), which 
diminishes oxidative respiration, however, does not induce mtUPR (Yoneda et al., 2004). 
Together, these observations suggest that disturbance of the fixed ratio of nuclear and 
mitochondrial encoded subunits (“mito-nuclear protein imbalance”) interferes with complex 
assembly and results in accumulation of unassembled subunits in the mitochondrial matrix, 
and, in turn induces mtUPR (Houtkooper, Mouchiroud, Knott, Williams, & Auwerx, 2013).  
HSP60 and HSP10 are upregulated in both the mRNA and protein level as part of the 
mitochondrial stress response (Martinus et al., 1996; Zhao et al., 2002). When the chaperonin 
activity is not sufficient, polypeptides can form terminally misfolded protein structures in the 
mitochondrial matrix. During the initial phase, these misfolded proteins can be degraded and 
recycled by the mitochondrial protease LONP1, which is also upregulated in response to 
mitochondrial stress (Zhao et al., 2002).  
Upregulation of HSP60, or its orthologs in lower organisms, is used as the key indicator of 
mtUPR induction (Durieux, Wolff, & Dillin, 2011; Houtkooper et al., 2013; H. Zhang, Ryu, 
Menzies, & Auwerx, 2016). CLPP or LONP1 upregulation is also utilized as an additional mtUPR 
marker by some researchers. However, their use is not consistent, which may be due to 
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variability in expression and response patterns depending on the type of cell/tissue, model 
organism, or method of stress exposure.  
Under normal conditions where no mitochondrial stress is present, HSP60/HSP10 chaperonin 
function is required for proper folding of newly synthesized nuclear-DNA-encoded 
mitochondrial proteins imported into the matrix. Accordingly HSP60 is required during 
development – Hsp60 deletion is lethal (Yoneda et al., 2004). HSP60 and HSP10 also function in 
the re-folding of structurally unstable proteins prone to aggregation. The role of mtUPR and 
other aspects of mitochondrial homeostasis in aging will be discussed in the next section. 
1.2.7 Mitochondria in aging and longevity 
Mitochondria accumulate multiple forms of damage during aging. Importantly, prevention or 
partial reversal of mitochondrial damage though genetic and pharmaceutical interventions can 
improve mitochondrial function and extend lifespan. Some of the aging-associated 
mitochondrial defects and animal models resistant to such deterioration will be introduced in 
the following sections. 
1.2.7.1 Accumulation of mtDNA damage with age 
In humans, mtDNA deletions increase with age in multiple tissues including diaphragm muscle 
(Hayakawa, Torii, Sugiyama, Tanaka, & Ozawa, 1991), brain (Corral-Debrinski et al., 1992; 
Cortopassi & Arnheim, 1990; Soong, Hinton, Cortopassi, & Arnheim, 1992), and heart 
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(Cortopassi & Arnheim, 1990). Mouse liver also shows accumulation of mtDNA deletions during 
aging (Piko, Hougham, & Bulpitt, 1988). An increase in mtDNA point mutations by age is 
detected in extraocular muscle of the human eye (Munscher, Muller-Hocker, & Kadenbach, 
1993; Munscher, Rieger, Muller-Hocker, & Kadenbach, 1993).  
Mitochondrial DNA is subject to oxidative damage at least 10-15 times more than nuclear DNA 
(Mecocci et al., 1993; Richter, Park, & Ames, 1988). Oxidative damage in mtDNA increases with 
age in human brain (Mecocci et al., 1993) and diaphragm muscle (Hayakawa et al., 1991), as 
well as in rat liver (Ames, Shigenaga, & Hagen, 1993). Age-associated escalation of oxidative 
damage is also detected in mitochondrial proteins (Sohal & Dubey, 1994).  
Another abnormality of mtDNA is occurrence of catenated mtDNA dimers, which indicates 
impaired separation of mtDNA molecules during replication. Abundance of catenated DNA 
increases by age in heart and brain tissues of mice (Piko, Bulpitt, & Meyer, 1984) (Bulpitt & 
Piko, 1984). A similar age-associated increase in catenated DNA also takes place in rat heart and 
kidney (Piko et al., 1984).  
mtDNA mutator mice 
Although the correlation between aging and increase in mtDNA mutations was established by 
the end of 90s, it was not known whether the mtDNA mutations were driving the aging process 
or vice versa. In order to assess the effects of mtDNA mutations in mice, a mouse model 
exhibiting accelerated accumulation of mtDNA alterations was generated by adding a defective 
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copy of mitochondrial DNA polymerase in mouse genome (Trifunovic et al., 2004). The “mtDNA-
mutator” (PolgAmut/mut) mice generate new mtDNA mutations resulting in 3 to 5-fold increase in 
point mutations and higher frequency of deletions at each mtDNA replication. Mutator mice 
demonstrated that increase in mtDNA mutations beyond physiologic levels induce severe 
pathology and mortality with maximum lifespan of ~15 months (Trifunovic et al., 2004). Males 
start losing weight around 4-5 months of age, while weight loss in females is observed after ~6 
months of age. As a reference point, decrease in body weight does not start before ~18 months 
of age in normal (B6;129) mice (Haines, Chattopadhyay, & Ward, 2001). Health defects in 
mtDNA-mutator mice are observed only after 25 weeks of age and gradually increase, 
suggesting an age-associated effect which requires accumulation of mtDNA mutations.  
However, accelerated health deterioration in mtDNA-mutator mice was not due to oxidative 
damage (Kujoth et al., 2005). As opposed to the view suggesting that accumulation of mtDNA 
mutations promotes aging by increasing free-radical production and oxidative damage, the 
mtDNA-mutator mice does not show any indication of increase in oxidative damage or reactive 
oxygen species despite highly elevated levels of mtDNA mutations and compromised 
mitochondrial function (Kujoth et al., 2005; Trifunovic et al., 2005; Trifunovic et al., 2004).  
These observations demonstrate that, in contrast to earlier assumptions, mtDNA alterations 
alone do not increase reactive oxygen species or oxidative damage. Importantly, the same 
results also demonstrate that loss of mtDNA integrity is sufficient to induce detrimental 
pathology and early mortality - but not through oxidative damage. How mtDNA mutations 
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cause deleterious effects is not known. Health defects in mtDNA-mutator mice are observed 
only after 25 weeks of age and gradually increased, suggesting an age-associated effect 
requiring accumulation of mtDNA mutations.  
1.2.7.2 Increase in mitochondrial oxidants and oxidative damage 
Oxidants are continuously produced as a part of metabolism. Highly reactive oxidants 
containing oxygen are called "reactive oxygen species (ROS)". Molecular oxygen (O2) is an 
abundant oxidant in mitochondria. When reduced by gaining an extra electron it forms a 
reactive oxygen species, superoxide (▪O2-). Superoxide interacts with protons (H+) to produce 
hydrogen peroxide (H2O2). Hydrogen peroxide reacts with two protons and two electrons to 
form water (H2O). However, hydrogen peroxide can also react with a single electron. This 
"partial reduction" of hydrogen peroxide produces another reactive oxygen species, hydroxyl 
radical (▪OH). Reactive oxygen species can interact with and modify almost any macromolecule 
including proteins, lipids, and nucleic acids. The damaging activity of reactive oxygen species on 
cellular structures is referred as "oxidative stress". Excessive oxidative damage in mitochondria 
can lead to cytochrome c release and apoptosis (Perier et al., 2005). 
During mitochondrial respiration, oxygen is normally reduced to water (discussed in section 
1.2.3). However, oxygen reduction does not always reach completion. Although with low 
frequency, incomplete oxygen reduction can produce superoxide radical and hydrogen 
peroxide, which may induce oxidative damage. Antioxidant enzymes protect the cell from the 
deleterious effects of the two species by facilitating their conversion into non-reactive 
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molecules. Superoxide dismutase converts superoxide into oxygen and hydrogen peroxide, 
which is converted to water by catalase.  
In rats, the rate of superoxide and hydrogen peroxide production in heart mitochondria 
increases with age despite comparable superoxide dismutase activity in young and old rats 
(Nohl & Hegner, 1978). Organic peroxide content in the mitochondrial membranes is also 
higher in old rats, suggesting an increase in oxidative damage by age.  
Oxidative damage is thought to contribute to aging, and it is suggested that reversal or 
protection from oxidative damage could lead to prolonged lifespan (Harman, 1956). Consistent 
with this view, resistance to oxidative damage in primary fibroblasts correlates with maximum 
lifespan in rodent and primate species (Pickering, Lehr, Kohler, Han, & Miller, 2014). Also, cross-
species studies of mammals indicate a negative correlation between maximum life span and 
rate of mitochondrial superoxide production and H2O2 release in liver, kidney, and heart (Ku, 
Brunk, & Sohal, 1993; Sohal, Svensson, & Brunk, 1990; Sohal, Svensson, Sohal, & Brunk, 1989). 
In flies, hydrogen peroxide release as well as oxidative protein damage in flight muscle 
mitochondria increases with age (Sohal & Dubey, 1994; Sohal & Sohal, 1991).  
Thioredoxin reductase 2 (TXNRD2) facilitates reduction of hydrogen peroxide; inhibition of 
TXNRD2 increases hydrogen peroxide release from mitochondria (Stanley et al., 2011). Activity 
of mitochondrial thioredoxin reductase (TXNRD2), but not of cytosolic thioredoxin reductases 
(TXNRD1 and TXNRD3), is elevated in cells from long-lived species of rodents, primates, and 
birds (Pickering, Lehr, Gendron, Pletcher, & Miller, 2017). Association of mitochondrial form of 
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thioredoxin reductase with longer lifespan is not limited to mammals and birds. Overexpression 
of mitochondrial Trxr-2 (TXNRD2 ortholog), but not of Trxr-1 (TXNRD1 ortholog), extends 
median lifespan in fruit flies (Pickering et al., 2017).  
Overexpression of mitochondrial superoxide dismutase (SOD-2; also Mn-SOD) (Hu et al., 2007) 
and mitochondria-targeted overexpression of catalase (Schriner et al., 2005) are found to 
extend mouse lifespan. However, there are also reports suggesting negative health effects 
(Levin et al., 1998) and no longevity effect of antioxidant overexpression in mice (Jang et al., 
2009; Levin, Christopher, & Crapo, 2005). Interestingly, young adult mice overexpressing 
extracellular superoxide dismutase show learning impairments (Levin et al., 1998). However, 
the same mice perform better than normal controls in learning and memory tasks if they are 
tested at old age (Levin et al., 2005; Levin et al., 2002). No effect on lifespan is detected in these 
mice (Levin et al., 2005). Previously reported lifespan extension in mice overexpressing SOD2 
has been questioned in later studies; although partial reversal of age-associated decline in ATP 
production is observed SOD2-overexpressing mice, no effect on lifespan was detected (Jang et 
al., 2009). Therefore, the prolongevity effect of antioxidant overexpression is not decisively 
established yet.   
1.2.7.3 Decline in ETC protein levels and respiratory function 
Enzymatic activity assays show that mitochondrial ETC complex I and IV content per total 
mitochondrial protein mass decrease with age in human skeletal muscle (Boffoli et al., 1994), 
rat diaphragm (Torii, Sugiyama, Takagi, Satake, & Ozawa, 1992), and rhesus monkey neocortex 
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(Bowling et al., 1993). A similar age-associated decrease is observed for ETC complex IV in 
human diaphragm (Muller-Hocker, 1990) and extraocular muscle (Muller-Hocker, 
Schneiderbanger, Stefani, & Kadenbach, 1992). In rats, cardiac protein levels of cytochrome c 
subunits Va, Vb, VIc, and ATP synthase subunit beta decrease 20-40% with age, while enzymatic 
activities of NADH-ubiquinone oxidoreductase and ATP synthase are reduced 46% and 25%, 
respectively (Preston et al., 2008). 
Consistent with a decline in protein levels of respiration complex subunits in mammals, rate of 
ATP production decreases with age in skeletal muscle of mice (Jang et al., 2009). A similar 
decline is described in rats. Compared to 6-month-old young adults, 24-month-old rats show 
20-25% decay in ATP production rate in heart muscle (Preston et al., 2008).  
Rate of respiration for ATP production in rats is stable from 3 months of age to adulthood, but it 
starts to decline at 16-20 months of age. Respiration rates in heart and skeletal muscle 
mitochondria of 28-month old rats is 17-19% lower than those of 12-month old rats (Chen, 
Warshaw, & Sanadi, 1972). An age-dependent decline in respiration rate is also documented in 
rabbit liver (Klein, Jenkins, Reviczky, & Fisher, 1981). 
1.2.7.4 Mitochondrial biogenesis pathway in long-lived mice 
Mice fed on a restricted diet, which live longer than mice with unrestricted access to food, 
exhibit indications of upregulated mitochondrial biogenesis. Calorie restricted (CR) mice show 
increased mitochondrial volume in skeletal muscle, and this increase requires PGC-1α 
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expression, which is also found to be upregulated in skeletal muscle of CR mice (Finley et al., 
2012). Calorie restriction (both 3-month and 12-month) increases mtDNA content, ATP 
concentration, and expression of the key regulator of mitochondrial biogenesis Pgc-1α and 
mitochondrial transcription factor Tfam at least two-fold in white adipose tissue, and to a lesser 
extent but significantly in brain, liver, heart, and brown adipose tissue (Nisoli et al., 2005). 
Skeletal muscle of CR adult mice (12-month old) also shows upregulated nuclear protein levels 
of PGC-1α and elevated oxygen consumption (Hempenstall, Page, Wallen, & Selman, 2012). 
Increased respiration is also noted in calorie restricted S. cerevisiae (S. J. Lin et al., 2002) and C. 
elegans (Houthoofd et al., 2002).  
Pgc-1α mRNA levels are elevated in epididymal fat and kidney from Ames (Menon et al., 2014) 
and GHR-KO mice (Gesing, Masternak, et al., 2011; Masternak et al., 2012). In GHR-KO mice, 
higher renal PGC-1α is documented also at protein level (Gesing, Bartke, et al., 2011). Skeletal 
muscle of GHR-KO mice shows higher average levels of Pgc-1α mRNA (Gesing, Masternak, et al., 
2011). Of note, aforementioned studies on Pgc-1α expression in GHR-KO mice analyzed either 
male or female mice for each tissue and the mice were fasted over-night prior to dissection 
(Gesing, Bartke, et al., 2011; Gesing, Masternak, et al., 2011). Assessment of Pgc-1α expression 
in a broader set of tissues and metabolic conditions in GHR-KO mice, as well as in other long-
lived mutant mice, is necessary to arrive a conclusion. 
As noted in previous sections, both Ames and GHR-KO mice are deficient in IGF-1 signaling. 
Since IGF-1 activity is generally associated with organismal growth and anabolic metabolism, 
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the counterintuitive Pgc-1α upregulation in IGF-1-deficient mice seems to be an indirect effect. 
It would be of interest to see whether Snell mice, which are also deficient in GH/IGF-1 signaling, 
have elevated expression of Pgc-1α and other genes involved in mitochondrial biogenesis. 
1.2.7.5 Mitochondrial stress response in aging and longevity 
Lifespan extension in C. elegans can be induced by partial defects in mitochondrial protein 
homeostasis including those caused by mutations in ETC genes (Feng, Bussiere, & Hekimi, 
2001), RNAi-mediated silencing of nuclear-encoded mitochondrial protein expression (Hamilton 
et al., 2005), and pharmacologic inhibition of mitochondrial translation (Tsang, Sayles, Grad, 
Pilgrim, & Lemire, 2001).  
Electron transport chain complex IV subunit cco-1 (“cytochrome c oxidase-1 subunit Vb”; C. 
elegans homolog of mammalian Cox5b) is one of the ETC genes whose inhibition results in 
prolonged lifespan in worms. It is found that, concurrent with lifespan extension, C. elegans 
deficient in cco-1 expression exhibit upregulated expression of hsp6 (“Heat shock protein 6”; 
mtUPR gene in C. elegans), suggesting involvement of mtUPR in nematode longevity (Durieux et 
al., 2011). Importantly, temporary knock-down of cco-1 during the larva stage is sufficient for 
inducing lifespan extension and hsp6 upregulation. Moreover, upregulated levels of hsp6 
expression persists throughout the worm lifespan even when the initial mitochondrial stress is 
discontinued. This observation indicated that short-term exposure to mitochondrial stress early 
in life can induce permanent reprogramming of the mtUPR pathway, and upregulation of 
mtUPR may be the factor that drives lifespan extension in worms. In line with this view, muscle-
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specific overexpression of Hsp70F, a putative mtUPR protein in nematodes, result in more than 
40% increase in worm lifespan (Yokoyama et al., 2002).  
Partial deficiency in expression of mitochondrial genes can also extend mouse lifespan. Mclk1 is 
the mouse orthologue of the C. elegans gene clk-1, a mitochondrial enzyme involved in 
ubiquinone biosynthesis. Mice homozygous for Mclk1 deletion (Mclk1-/-) are not viable 
(Levavasseur et al., 2001). However, deletion of only one copy of Mclk1 increases both mean 
and the maximum lifespan, suggesting evolutionary conservation of mitochondrial-defect-
mediated longevity pathway. Mitochondrial defects including reduced ATP synthesis are noted 
in Mclk1+/- mice (Lapointe & Hekimi, 2008), but it is not known whether they exhibit 
upregulated mtUPR. 
A cross-species study found a correlation between maximum lifespan and HSP60 levels in liver, 
heart, and brain among species of mammals (Salway, Gallagher, Page, & Stuart, 2011). 
However, it is not yet known whether mtUPR is elevated in any of the long-lived mouse models.  
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1.3  Regulation of mRNA translation by N6-adenosine methylation 
Molecular pathways of the cell are highly regulated by chemical modifications targeting 
protein, DNA, and RNA molecules. Phosphorylation of certain key proteins, for example, can 
alter a wide range of cellular functions including protein synthesis, replication, and apoptosis. 
Eukaryotic messenger RNA molecules are also subject to post-synthesis modifications. 
1.3.1 N6-methyladenosine mRNA modification 
Polyadenylation of mRNA in eukaryotes was discovered in 1971 (Darnell, Wall, & Tushinski, 
1971; Edmonds, Vaughan, & Nakazato, 1971; S. Y. Lee, Mendecki, & Brawerman, 1971). This 
important finding led to rapid development of RNA isolation protocols based on mRNA 
polyadenylation which allowed preparation of sufficiently pure mRNA samples by reducing 
rRNA contamination (Brawerman, Mendecki, & Lee, 1972; Nakazato & Edmonds, 1972; 
Sheldon, Jurale, & Kates, 1972). In 1974, Perry and Kelley isolated polyadenylated mRNAs from 
mouse L cells labeled with 3H methyl methionine and found that mRNA molecules were 
methylated in both ribose and base moieties (Perry & Kelley, 1974). The methylated residue 
was identified as N6-methyladenosine (Desrosiers, Friderici, & Rottman, 1974; Perry, Kelley, 
Friderici, & Rottman, 1975).  
Although the methylation of N6-adenosine (N6-methyladenosine; m6A) in eukaryotic mRNA had 
been described by independent groups by 1975, it was not readily accepted as a biologically 
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relevant modification. The arguments about purity of analyzed mRNA samples persisted for the 
next couple of decades. 
Nevertheless, in 2012, two independent reports reignited the interest in m6A modifications. 
Application of transcriptome-wide m6A-specific methylated mRNA immunoprecipitation 
followed by high-throughput sequencing referred as “m6A-seq” (Dominissini et al., 2012) or 
“MeRIP-seq”(Meyer et al., 2012) led to the identification of ~13 thousand putative m6A sites. 
The m6A sites were found on coding sequences, 3’UTR, and with less abundance in the 5’UTR. 
The m6A distribution data from these two transcriptome-wide studies established the first m6A 
methylome. They also showed that the m6A modification is dynamically regulated and 
preferentially associated with certain mRNA-binding proteins (Dominissini et al., 2012; Meyer 
et al., 2012).  
Transcriptome-wide identification of m6A sites at single nucleotide resolution 
A transcriptome-wide m6A screening study using “m6A individual-nucleotide cross-linking and 
immunoprecipitation (miCLIP)” on human embryonic kidney cells, identified ~9000 putative 
m6A sites (Linder et al., 2015). Another m6A-seq analysis of changes in methylation patterns 
upon heat stress in mouse embryonic kidney cells suggested that increased m6A marks in 5’UTR 
may play a role in translation of stress-induced mRNAs, and provided hints for an alternative 
translation mechanism not dependent on the 5’7-methylguanosine (m7G) cap (J. Zhou et al., 
2015). Independently, an in vitro toeprinting analysis using m6A-containing synthetic mRNA, 
which allows dissection of individual components required for translation initiation, indicated 
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that translation-initiation complexes can form on m6A-contatining mRNA even in the absence of 
cap(m7G)-binding initiation factor eIF4E (Meyer et al., 2015).  
In addition to setting the stage for investigation of m6A-mediated cap-independent translation 
as a putative translation regulation mechanism, these studies provided insightful findings on 
the dynamic regulation of m6A modifications, which will be discussed next. 
1.3.1.1 Dynamic regulation of m6A modifications 
The m6A modification status of mRNA transcripts is determined by the opposing actions of 
enzymes acting as m6A “writers”, which add methyl groups to adenine residues, and “erasers”, 
which remove these methyl marks. 
1.3.1.2 Addition of m6A modifications 
Early biochemical studies investigating the methylation of 20-nucleotide-long RNA polymers in 
a solution containing HeLa cell nuclear extracts found that m6A modifications were 
preferentially located on specific mRNAs containing the consensus sequence GGACU with some 
variations (Harper, Miceli, Roberts, & Manley, 1990). Combined with other reports suggesting 
GAC, and with a lower frequency AAC, as targets of N6-adenosine methylation, the nucleotide 
sequence G/A - m6A - C emerged as the consensus sequence (Schibler, Kelley, & Perry, 1977). 
The proposed GAC / AAC consensus sequence has been confirmed by transcriptome-wide 
studies and broadened to DRACH (D=A/G/U; R=G(%70)/A(30%); H=A/C/U) motif, where A in the 
middle is the target of methylation (Linder et al., 2015). Of note, it is also established that not 
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all DRACH sequences are methylated; and most, but not all, m6A modifications are found on 
DRACH sites (Linder et al., 2015).  
The sequence specific nature of methylation implied that m6A modifications did not occur 
randomly and presumably involved specific methyltransferases indicating the presence of a 
regulated methylation pathway with biological relevance. 
1.3.1.2.1 METTL3 and METTL14 
Methylation of N6-adenosine mRNA residues is thought to be carried out by two 
methyltransferases designated methyltransferase-like 3 (METTL3) and 14 (METTL14).  
METTL3 (also “N6-adenosine-methyltransferase 70 kDa subunit”) was purified from a protein 
complex referred as “mRNA N6-adenosine methyltransferase” due to its ability to add methyl 
groups to N6-adenosines in vitro (Bokar, Rath-Shambaugh, Ludwiczak, Narayan, & Rottman, 
1994). Specificity of its methyltransferase activity on the previously described GAC and AAC 
sequences confirmed its role in N6-adcenosine methylation (Narayan, Ludwiczak, Goodwin, & 
Rottman, 1994). 
METTL3 has a S-Adenosyl methionine (SAM)-binding methyltransferase domain. Its homologues 
are found in the yeast S. cerevisiae (Clancy, Shambaugh, Timpte, & Bokar, 2002) and fruit fly D. 
melanogaster (Hongay & Orr-Weaver, 2011), both referred as “inducer of meiosis 4 (Ime4)”.  
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METTL14 is the second of the two methyltransferases found in the N6-adenosine-
methyltransferase complex. It was recently identified by its interaction with METTL3 
(Havugimana et al., 2012). Similar to METTL3, it methylates N6-adenosines residing in GAC 
sequences in vitro (Ping et al., 2014), and forms protein complexes with METTL3 in cells (Liu et 
al., 2014; Y. Wang et al., 2014).  
Both METTL3 and METTL14 can individually mediate the formation of m6A mRNA modifications 
in vitro; however, when they are both present, their total methyltransferase activity is higher 
than the sum of their individual activities (Liu et al., 2014; Y. Wang et al., 2014), suggesting that 
their interaction may be required for increased enzymatic activity and either one of them is not 
sufficient alone. Supporting this idea, single knockdown of Mettl3 or Mettl14 in mouse 
embryonic stem cells results in partial reduction of m6A modifications and disrupts stem cell 
maintenance (Y. Wang et al., 2014). It is not known whether the two enzymes target distinct 
populations of mRNAs.  
1.3.1.2.2 WTAP 
Wilms tumor 1-associated protein (WTAP) is also found in the N6-adenosine methyltransferase 
complex (Liu et al., 2014). Although it does not show enzymatic activity, its interaction with N6-
adenosine methyltransferase subunits may be required for efficient mRNA methylation (Zhong 
et al., 2008).  
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1.3.1.3 Removal of m6A modifications 
The discovery of enzymes that could reverse m6A modifications was particularly important. The 
opposing activity of m6A methyltransferases and demethylases would provide a mechanism for 
dynamic m6A regulation. Enzymatic control of N6-adenosine methylation status in both 
directions was highly suggestive for a potential role of m6A modifications in cellular function.  
The reversion of N6-adenosine modifications is achieved by demethylation. Two enzymes, fat 
mass and obesity-associated protein (FTO) and α-ketoglutarate-dependent dioxygenase alkB 
homologue 5 (ALKBH5), are thought to mediate demethylation of m6A.  
Although yeast has the machinery for m6A addition (Schwartz et al., 2013), no enzymes for m6A 
demethylation have been found so far. So, in some organisms negative regulation of m6A 
mRNAs may be through passive mechanisms such as mRNA degradation.  
1.3.1.3.1 FTO 
The Fto gene was identified in 1999; its name (Peters, Ausmeier, & Ruther, 1999) reflects its 
deletion in fused-toes (ft) mice (van der Hoeven et al., 1994). In 2007, multiple studies found 
that human obesity showed a strong association with a single nucleotide polymorphism in the 
FTO gene which increases FTO expression. When the linkage between FTO and obesity had 
been established, its name was changed to “fat mass and obesity-associated protein,” 
abbreviated as “FTO,” avoiding inconsistency in the literature.  
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Fto-deficient mice are leaner, but show reduced growth starting 2 days after birth and exhibit 
40% decrease in survival at 4 weeks of age (Fischer et al., 2009). In humans, FTO is required for 
development. A rare FTO mutation causing loss of function was detected in a family with severe 
phenotype. All eight children homozygous for the mutation had multiple health problems and 
died before the age of three. Thus, FTO function is indispensable for mammals.  
FTO can demethylate m6A. FTO is closely related to the bacterial alpha-ketoglutarate-
dependent dioxygenase (AlkB) and its human homologues ABH2-3 (Gerken et al., 2007; 
Sanchez-Pulido & Andrade-Navarro, 2007). It catalyzes the oxidative demethylation of 
methylated thymidine and uracil (Gerken et al., 2007; G. Jia et al., 2008). Importantly, FTO can 
demethylate m6A. Its overexpression in HeLa cells reduces m6A levels in mRNA, while its knock-
down increases them.  
1.3.1.3.2 ALKBH5 
Alkbh5-deficient mice are viable and exhibit good health at adulthood, except for a lower rate 
of successful breeding, presumably due to an increase in apoptotic cells in the testes and 
compromised spermatozoal motility detected in males (Zheng et al., 2013). Testis-specific 
deficiency in Alkbh5-/- is consistent with the pattern of Alkbh5 expression in tissues of normal 
mice; the highest Alkbh5 mRNA levels were found in testis, followed by lung, spleen, kidney and 
liver (Zheng et al., 2013).  
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ALKBH5 demethylates m6A. Alkbh5-/- mice also show an increase in m6A levels in lung and in 
testicular cells purified from seminiferous tubules. In HeLa cells, siRNA-mediated knock-down of 
ALKBH5 results in an increase in relative amount of m6A compared to total cellular mRNA, 
whereas ALKBH5 overexpression decreases it (Zheng et al., 2013). The increase in m6A in the 
tissues of Alkbh5 knock-out mice where it is normally expressed the most, and in HeLa cells 
with suppressed ALKBH5 expression, suggest that ALKBH5 may have a role in m6A 
demethylation. Indeed, biochemical analysis show that recombinant human ALKBH5 can 
completely demethylate m6A in single stranded RNA in vitro (Zheng et al., 2013), with an 
activity comparable to FTO (G. Jia et al., 2011). Moreover, proteomics analysis of mRNA-bound 
proteins in human embryonic kidney cells identified 800 mRNA-binding proteins including 
ALKHB5, which is confirmed to bind mRNA in an independent assay (Baltz et al., 2012).  
Thus, the role of ALKHB5 and FTO in m6A demethylation is well established, but the functional 
consequences of m6A regulation have been uncovered only in last few years with the discovery 
of a new mRNA translation mechanism.  
1.3.1.4 Recognition of m6A modifications 
Enzymatic control of m6A addition by METTL3 and METTL14, and its removal by FTO and 
ALKHB5, suggested a functional role for m6A modifications. Alteration of protein binding by 
chemical modification of nucleoside residues is a common regulatory mechanism in eukaryotes. 
Studies of RNA pulldown in mammalian cells followed by mass spectrometry analysis identified 
several proteins that preferentially bind to mRNAs bearing m6A modifications (m6A-mRNAs), 
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including YTH domain-containing family (YTHDF) proteins YTHDF1, YTHDF2, and YTHDF3 
(Dominissini et al., 2012; X. Wang et al., 2014).  
1.3.1.4.1 YTHDF1 
Research on m6A function highly benefited from development of new transcriptome-wide 
techniques for the assessment of protein-binding sites on mRNAs in living cells. Analysis of 
mRNA-protein interactions in HeLa cells by photoactivatable ribonucleoside crosslinking and 
immunoprecipitation (PAR-CLIP)(C. Zhang & Darnell, 2011) and RNA immunoprecipitation 
followed by high throughput sequencing (RIP-seq) showed that YTHDF1 binds to m6A bearing 
mRNAs and facilitates their translation in HeLa cells (X. Wang et al., 2015).  
Knock-down of YTHDF1 does not alter the m6A/A ratio in HeLa cells, suggesting that YTHDF1 
associates with but does not modify m6A residues. However, overexpression of YTHDF1 in the 
same cell line increases the m6A/A ratio in mRNA. This may represent an artificial increase in 
m6A-mRNA stability as a result of elevated YTHD1 binding or may represent a stabilizing effect 
of active translation. Nevertheless, the current data is not sufficient for ruling out a possible 
effect of YTHDF1 on mRNA stability.  
Experiments in HeLa cells with N_YTHDF1(N-terminal-domain)-tethered IRES reporters with 
varying dependency on eIFs suggested that YTHDF1-mediated translation requires eIFs and 
probably requires eIF4G-dependent loop formation (X. Wang et al., 2015).  
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1.3.1.4.2 YTHDF2 
An analysis of the individual effects of YTHDF1 and YTHDF2 knock-downs in HeLa cells showed 
that 50% of the mRNA transcripts bound by one of them are also bound by the other. YTHDF1 
knock-down decreases the translation of these “common target” mRNAs without altering their 
average lifetime; for YTHDF2, on the other hand, knock-down increases their average lifetime, 
with little effect on translation efficiency. These observations suggest that while YTHDF1 
binding promotes translation, YTHDF2 binding promotes degradation (X. Wang et al., 2015).  
Seemingly opposing actions of the two YTHDF proteins may be ideal for a hypothetical scenario 
where a short pulse of protein synthesis is required: YTHDF2 would promote degradation of 
m6A-mRNAs, leaving a small time window for their translation, and YTHDF1 would enable rapid 
translation of those transiently-available mRNAs. In agreement with this idea, pulse-chase 
experiments suggest a sequential binding – most of the time, YTHDF1 binds to nascent mRNAs 
earlier than YTHDF2 (X. Wang et al., 2015).  
1.3.1.4.3 Other proteins 
Methylated RNA-binding 1 (Mrb1), the yeast homologue of YTHDF proteins, also has a YTH RNA 
binding domain, and binds to m6A-mRNAs in yeast (Schwartz et al., 2013). Pulldown studies on 
yeast extracts also found additional proteins associated with m6A-mRNAs. However, since 
pulldown results do not discriminate between proteins directly interacting with m6A 
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modifications and those interacting with other parts of the ribonucleoprotein complex, 
assessment of the role of these proteins on m6A-mRNA recognition requires further research.  
1.3.2 m6A-mediated cap-independent translation 
Protein synthesis in eukaryotic cells is mainly achieved by a mechanism referred as “cap-
dependent translation”, which requires recognition of the 5’ N7methylguanosine(m7G) cap for 
translation initiation. Briefly, the eukaryotic translation initiation complex eIF4F, which consists 
of initiation factors eIF4E, eIF4G, and eIF4A, binds to the 5’cap and recruits 40S ribosomal 
subunit and other initiation factors to initiate mRNA translation. However, some mRNAs can be 
translated by a cap-independent process, which can proceed even under conditions where 
eIF4F-mediated cap-dependent translation initiation is compromised. One such mechanism 
relies on 5’UTR internal ribosome entry site (IRES) motifs which are found in viral mRNAs but 
rarely observed in eukaryotic mRNAs. Maintenance of eukaryotic protein synthesis under 
conditions where cap-dependent translation initiation machinery is not functional indicates 
existence of an alternative translation pathway.  
The proposal of m6A-mediated cap-independent translation as an alternative translation 
mechanism is very recent. The first hints of a possible role of 5’UTR m6A modifications in 
facilitating mRNA translation independent of the cap-dependent translation initiation 
mechanism were provided by studies combining high-throughput approaches including 
transcriptome-wide immunoprecipitation of m6A-containing mRNAs, parallel sequencing, and 
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use of genomic database resources for sequence alignment (Meyer et al., 2015; J. Zhou et al., 
2015). Follow up studies (Coots et al., 2017) established that certain mRNA transcripts bearing 
5’UTR m6A modifications can be translated in a cap-independent manner. This mechanism is 
referred as m6A-mediated cap-independent translation (hereafter “m6A-CIT”). 
1.3.2.1 Current model of m6A-mediated cap-independent translation regulation 
According to a current model (Fig. 1.1), METTL3 and METTL14 preferentially methylate 
adenosine residues found in DRACH (D=A/G/U; R=G/A; H=A/C/U) motifs to form N6-
methyladenosine. The N6-methyladenosine modifications can be reversed by two demethylases 
FTO and ALBH5. YTHDF proteins recognize and bind to m6A-bearing mRNAs and facilitate their 
translation either by recruiting translation initiation factors or by increasing their stability. 
ABCF1 has been suggested as another m6A “reader” in a recent report (Coots et al., 2017), but 
further studies are needed to confirm its role in m6A-CIT.  
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Figure 1.2 Regulation of m6A-CIT by “writer”, “eraser” and “reader” proteins.  
METTL3 and METTL14 add m6A modification to mRNA transcripts in 5'UTR. FTO and ALKBH5 
remove m6A marks. YTHDF1 and YTHDF2 recognize m6A marks and promote translation of m6A-
bearing transcripts through m6A-CIT. 
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Chapter 2 -  Mitochondrial stress response in fibroblasts from long-lived Snell mice 
2.1  Introduction 
Primary fibroblasts isolated from Snell mice are more resistant to cell death induced by UV 
radiation, hydrogen peroxide, cadmium, and paraquat (Murakami et al., 2003). Among those, 
paraquat is known to induce mtUPR in C. elegans (Yoneda et al., 2004). Hence, higher paraquat 
resistance of Snell fibroblasts may be partly due to an improved mitochondrial stress response. 
It is not known whether Snell fibroblasts exhibit elevated mtUPR.  
A recent study showed that, primary cells derived from long-lived Surf1 -/- mice (Dell'agnello et 
al., 2007) exhibit higher survival rate and mtUPR protein levels after treatment with certain 
doses of paraquat (Pharaoh, Pulliam, Hill, Sataranatarajan, & Van Remmen, 2016). Basal 
mtUPR, as measured by the abundance of mtUPR proteins HSP60 and LONP1, is also higher in 
primary fibroblasts from Surf1 -/- mice. Mitochondrial function was not assessed in this study, 
so it is not known to what extent Surf1 -/- fibroblasts, which show elevated mtUPR, can 
maintain ATP production or oxidative respiration after paraquat treatment. 
The mitochondrial stress response pathway can be analyzed in two different parameters. The 
first parameter is “basal mtUPR”, which is measured by abundance of mtUPR proteins in the 
absence of any imposed mitochondrial stressor. The second parameter is “mtUPR induction”, 
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which is the percentage increase in the mtUPR protein levels after exposure to a specific form 
and dose of stress. Since the cell culture conditions may intrinsically induce mitochondrial 
stress, the “basal mtUPR” measurements in cell culture studies may not be sufficient for 
assessment of mtUPR. We measure both parameters to understand how Snell cells differ from 
normal cells in (i) basal expression levels of mtUPR proteins, and (ii) their capacity to respond to 
mitochondrial stress.  
Prior data on primary fibroblasts isolated from Snell dwarf mice indicate comparable 
mitochondrial abundance (Page et al., 2009). However, similar levels of mitochondrial content 
does not imply comparable mitochondrial function, as exemplified by brown fat mitochondria 
in Pgc-1α-/- mice, where mitochondrial function is compromised despite normal levels of 
mitochondrial abundance (Leone et al., 2005). In addition to mtUPR, we assess mitochondrial 
function after mitochondrial stress exposure by measuring cellular ATP content and real-time 
oxidative respiration rates in normal and Snell cells.  
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2.2  mtUPR in Snell cells in response to mitochondrial stress 
HSP60 is required for folding of mitochondrial peptides into functional proteins, and its 
expression increases as a part of the mtUPR (Martinus et al., 1996). Doxycycline, an antibiotic of 
the tetracycline class, binds to the larger subunit of bacterial and mitochondrial ribosomes in 
their mRNA-bound state. Doxycycline binding halts mitochondrial translation, results in loss of 
ribosome-bound mRNA molecules through degradation, disrupts electron transport chain 
protein stoichiometry, and induces mtUPR.  
We compared levels of HSP60 in Snell and control fibroblasts with or without exposure to 
doxycycline. HSP60 levels in Snell cells were significantly elevated compared to normal cells 
without exposure to doxycycline (Fig. 2.1A, B). Doxycycline treatment increased HSP60 levels in 
both normal and Snell cells, as expected (p=0.001 for drug effect), and Snell cells had higher 
levels of HSP60 than normal cells. We did not detect a difference in the response of Snell versus 
normal cells by two-way ANOVA interaction analysis (p=0.19). Another indicator of mtUPR, 
mitochondrial protease LONP1, was also elevated in Snell cells with or without doxycycline 
exposure (Fig. 2.1A, C). The degree of LONP1 upregulation in response to doxycycline did not 
differ between normal and Snell cell types. 
Thiamphenicol, another inducer of mtUPR, blocks mitochondrial translation by interacting with 
the smaller subunit of the mitochondrial ribosome, a mode of action distinct from that of 
doxycycline. Compared to normal cells, we noted significantly higher levels of HSP60 in Snell 
cells (Fig. 2.2A, B), regardless of thiamphenicol treatment. In response to thiamphenicol 
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treatment, HSP60 induction was higher in Snell cells (p=0.0005 for the interaction term). Snell 
cells had higher LONP1 levels with or without thiamphenicol exposure, but unlike doxycycline, 
thiamphenicol had no significant effect on LONP1 levels (Fig. 2.2A, C). 
We considered the hypothesis that elevated levels of HSP60 and LONP1 might reflect higher 
levels of mitochondria in Snell fibroblasts, despite flow cytometric data to the contrary (Page et 
al., 2009). We therefore measured levels of ATP5A and UQCRC2, mitochondrial ETC proteins 
encoded in the nucleus, and saw no difference between Snell and control cells (Fig. 3A-B). 
Differences in mitochondrial content in two cell populations can also be detected by comparing 
mtDNA/nDNA ratios. We measured mtDNA/nDNA ratio in Snell and normal cells by performing 
qPCR for nucleotide sequences residing in the Atp6 gene in mtDNA and in the Hsp60 gene in 
nDNA. We found no differences in ratio of mitochondrial DNA to nuclear DNA (Fig. 2.4A). We 
confirmed our findings with another pair of mtDNA/nDNA sequences residing in mitochondrial 
CoxI and nuclear CoxIVi genes, both of which encode subunits of ETC complex IV (Fig. 2.4B).  
Taken together, our results indicate that the mitochondrial chaperone HSP60 and 
mitochondrial protease LONP1, two components of the mitochondrial stress response, are 
elevated in Snell cells, and remain so after exposure to either of two inducers of mitochondrial 
stress. 
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Figure 2.1 HSP60 and LONP1 protein levels after doxycycline treatment.  
(A) Immunoblot for HSP60 and LONP1 in normal and Snell cells after 48 hr. exposure to control 
media or media with 30 ng/ul doxycycline. β-actin is shown as a loading control. (B) Mean and 
SEM for N=6 mice for HSP60 and (C) LONP1. (*) indicates p < 0.05 by Student’s t-test for 
comparison between normal and Snell cells. Results of two-factor ANOVA are shown in the 
boxed inset, with p-values for the interaction (“Int.”) effects.   
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Figure 2.2 HSP60 and LONP1 protein levels after thiamphenicol treatment.  
(A) Immunoblot for HSP60 and LONP1 in normal and Snell cells after 48 hr. exposure to control 
media or media with 50 ng/ul thiamphenicol. Lane ‘Mt.’ is mitochondria sample isolated from 
rat heart as positive control. (B) Results for HSP60 and (C) LONP1. (*) indicates p < 0.05; (**) 
indicates p < 0.01 by Student’s t-test for comparison between normal and Snell cells (N=3-4). 
Results of two-factor ANOVA are shown in the boxed inset, with p-values for the Interaction 
(“Int.”) effects.   
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Figure 2.3 Levels of mitochondrial proteins in normal and Snell cells. 
(A) Immunoblot for HSP60 and mitochondrial proteins ATP5A and UQCRC2 in normal and Snell 
fibroblasts; with β-actin shown as a control. Three mice of each genotype are shown. (B) 
Statistical results for N=3 mice of each genotype. (*) indicates p < 0.05 by Student’s t-test for 
comparison between normal and Snell cells.  
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Figure 2.4 Mitochondrial DNA to nuclear DNA ratios in normal and Snell cells.  
Ratio of mitochondrial DNA levels to nuclear DNA levels measured by (A) Atp6/Hsp60, and (B) 
as CoxI/CoxIV in primary fibroblasts from normal and Snell mice (N=6). No significant difference 
between normal and Snell fibroblasts is detected by Student’s t-test.  
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2.3  Electron transport chain protein stoichiometry after stress exposure 
The electron transport chain (ETC), a multi-component system needed for oxidative respiration, 
is formed by a combination of peptides, some of which are encoded in nuclear DNA and others 
in mitochondrial DNA. In order to examine the relative levels of mitochondrial versus nuclear 
transcripts after mitochondrial stress, we measured the change in the expression of mtDNA-
encoded cytochrome c oxidase subunit 1 (CoxI), and nDNA-encoded cytochrome c oxidase 
subunit 4 (CoxIVi), each of which is a subunit of ETC complex IV.  
Nuclear DNA-encoded gene expression (CoxIVi) was not inhibited by doxycycline in either Snell 
or control cells, confirming specific inhibition of mitochondrial translation and reduction in 
mitochondrial mRNA levels (Fig. 2.5A). Of note, a change in the opposite direction was noted, 
where nDNA-encoded CoxIVi transcript levels were higher after doxycycline treatment. 
We observed a decrease of more than 50% in the expression of mtDNA-encoded CoxI in normal 
cells exposed to doxycycline, but doxycycline had no effect in Snell cells, suggesting resistance 
of Snell cells to doxycycline-mediated reduction of mitochondrial transcript levels (Fig. 2.5B). 
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Figure 2.5 Snell cells maintain mtDNA-encoded CoxI transcript levels after doxycycline 
exposure.  
(A) Average values of Nuclear-DNA-encoded (CoxIVi) and (B) mitochondrial-DNA-encoded (CoxI) 
transcript levels in normal and Snell fibroblasts. Error bars represent SEM. (*) indicates p < 0.05 
by Student’s t-test for comparison between normal and Snell cells (N=6). Results of two-factor 
ANOVA are shown in the boxed inset, with p-values for the Interaction (“Int.”) effects.  
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2.4  Induction of the mitochondrial biogenesis pathway in response to mitochondrial 
stress 
We considered two possible explanations for maintained mtDNA-encoded gene expression in 
Snell cells. The efficacy of doxycycline might be low on Snell cells; the failure of the drug to halt 
mitochondrial translation and induce degradation of ribosome-bound mRNAs might be due, for 
example, to rapid degradation of the drug by Snell fibroblasts. Alternatively, doxycycline might 
inhibit mitochondrial translation effectively, but Snell cells may have a mechanism to 
compensate for this effect.  
To address the first idea, we noted that in both cell types doxycycline treatment resulted in a 
similar upregulation of Hsp60 and Hsp10 gene expression, which confirms that this drug is 
indeed effective on Snell fibroblasts, and activates the mtUPR as expected (Fig. 2.6). 
Accordingly, we next focused on pathways which might protect Snell cells from doxycycline 
effects by increasing mitochondrial transcription and biogenesis. We found that, in response to 
doxycycline treatment, the level of increase in mRNA for Tfam (Mitochondrial Transcription 
Factor A), a regulator of mitochondrial transcription, was 2-fold higher in Snell cells (Fig. 2.7A). 
In addition, mRNA for Pgc-1α, the main regulator of mitochondrial biogenesis, was upregulated 
only in Snell cells (Fig. 2.7B). Intrigued by Snell cell-specific upregulation Pgc-1α transcript levels 
by doxycycline, we measured PGC-1α protein levels before and after exposure to 
thiamphenicol, which also induces mitochondrial stress. Thiamphenicol exposure led to higher 
PCG-1α protein levels in Snell cells compared to control cells (Fig. 2.8A, B).  
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We also noted that, prior to stress exposure, Snell fibroblasts showed higher PGC-1α protein 
expression (Fig. 2-8A, B) despite comparable mRNA levels of (Fig 2.7A, B). This phenotype is 
investigated separately and presented in Chapter 4.   
 
Figure 2.6 Normal and Snell cells show similar levels of Hsp60 and Hsp10 mRNA upregulation. 
(A) Mean Hsp60 and (B) Hsp10 transcript levels in normal and Snell cells before and after 
doxycycline treatment. Error bars represent SEM. (*) indicates p < 0.05 by Student’s t-test for 
comparison between mock and doxycycline treated cells (N=6).   
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Figure 2.7 Tfam and Pgc-1α are upregulated in Snell cells in response to mitochondrial stress.  
(A) Tfam and (B) Pgc-1α mRNA levels after doxycycline treatment in normal and Snell primary 
fibroblasts for N=6 mice. Error bars represent SEM. (*) indicates p < 0.05 by Student’s t-test for 
comparison between normal and Snell cells. Results of two-factor ANOVA are shown in the 
boxed inset, with p-values for the Interaction (“Int.”) effects.  
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Figure 2.8 Higher levels of PGC-1α protein expression in Snell cells after mitochondrial stress.  
(A) Western blot image and (B) average values for PGC-1α protein expression after 
thiamphenicol treatment in normal and Snell fibroblasts for N=3-4 mice. Error bars represent 
SEM. (*) indicates p < 0.05 by Student’s t-test for comparison between normal and Snell cells. 
Results of two-factor ANOVA are shown in the boxed inset, with p-values for the Interaction 
(“Int.”) effects.  
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2.5  Snell cells are resistant to mitochondrial stress 
Snell fibroblasts were previously found to exhibit higher survival rates (as measured by the 
WST-1 cell viability assay) compared to those of normal cells after exposure to UV radiation, 
hydrogen peroxide, paraquat, and cadmium (Murakami et al., 2003). Our results demonstrating 
elevated levels of basal and induced mtUPR in Snell cells (Figures 2.1 and 2.2) suggested that 
Snell cells might be better protected from mitochondrial stressors, such as doxycycline.  
Treatment of fibroblasts with 30 ng/μl doxycycline does not induce cell death in 48 hours, but 
upregulates mtUPR in primary mouse fibroblasts. To investigate whether Snell fibroblasts resist 
lethal and metabolic effects of mitochondrial stress, we measured cell viability using a WST-1 
assay after exposing cells to 30 ng/μl and higher doses of doxycycline for 72 hours. Both normal 
and Snell fibroblasts showed a dose-dependent response (Fig. 2.9A). The Lethal Dose 50 (LD50), 
the dose of doxycycline that kills 50% of the initial population, was 2 fold higher in Snell cells 
(Fig. 2.9B), indicating elevated resistance to doxycycline-mediated cell death.  
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Figure 2.9 Snell cells survive higher doses of doxycycline-induced mitochondrial stress. 
(A) Cell viability (WST-1 assay) after 72-hour incubation in media with varying doses of 
doxycycline. Each symbol represents cells from an individual mouse; the same mice were used 
to generate data at each dose of doxycycline. (B) LD50 for normal and Snell cells. Normal cells 
are represented by dark circles; Snell cells are represented by light triangles for N=6 mice for 
each group. Horizontal bars represent the mean for each group. (*) indicates p < 0.05 by 
Student’s t-test for comparison between normal and Snell cells. Results of two-factor ANOVA 
are shown in the boxed inset, with p-values for the Interaction (“Int.”) effects.  
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2.6  Mitochondrial function after stress exposure: Cellular ATP content 
To gain a better understanding of the effect of mitochondrial stress exposure on mitochondrial 
function in Snell and normal cells, we measured cellular ATP content after incubating cells in 
medium containing increasing doses of doxycycline. Normal cells lost 60% of their cellular ATP 
content after 72 hours of 30 ng/μl doxycycline treatment, whereas Snell cells maintained ATP 
content under the same conditions. When the doxycycline dose was increased to 60 ng/μl, 
normal cells lost almost all their ATP, while Snell cells retained 25% of initial ATP content (Fig. 
2.10A). 
In order to rule out the possibility that preservation of ATP content in Snell cells was because of 
lower ATP consumption rate instead of maintenance of ATP generation, we treated cells with 
rotenone, a chemical inhibitor of ETC complex I. Rotenone suppresses ATP production but does 
not directly disturb mitochondrial proteostasis or induce mtUPR; If Snell cells maintained ATP 
levels because they consumed less ATP, cellular ATP content would also be maintained when 
ATP synthesis was blocked by rotenone. However, rotenone treatment caused similar loss of 
ATP levels in normal and Snell cells, and there was no detectable difference in cellular ATP 
content (Fig. 2.10B), implying that normal and Snell cells have similar ATP consumption rates 
under these conditions. Taken together, our results indicate that Snell cells are able to maintain 
cellular ATP content at a higher level than normal cells after doxycycline-induced mitochondrial 
stress. 
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Figure 2.10 Snell cells maintain cellular ATP content after mitochondrial stress exposure.  
(A) Cellular ATP content after 72 hr. exposure to doxycycline, and (B) rotenone, which does not 
induce mtUPR. Normal cells are represented by dark circles; Snell cells are represented by light 
triangles for N=5-6 mice for each group. Horizontal bars represent the mean for each group. (*) 
indicates p < 0.05 by Student’s t-test for comparison between normal and Snell cells. Results of 
two-factor ANOVA are shown in the boxed inset, with p-values for the Interaction (“Int.”) 
effects.  
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2.7  Mitochondrial function after stress exposure: Oxidative respiration 
A more direct indicator of mitochondrial function is the rate of oxidative respiration. In order to 
assess whether mitochondrial respiration is maintained after pre-exposure to mitochondrial 
stress, we exposed primary fibroblasts from normal and Snell mice to doxycycline (0, 30, and 60 
ng/μl for 24 hrs.) pre-treatment followed by an hour of rest-period in fresh medium in the 
absence of doxycycline, and then measured oxidative phosphorylation rates using the Seahorse 
system (Fig. 2.11). Of note, neither 30 ng/μl nor 60 ng/μl doxycycline treatment induces cell 
death at this timepoint, but does trigger mtUPR in primary mouse fibroblasts and hepatocytes 
(Houtkooper et al., 2013). 
 
Figure 2.11 Experimental design for measurement of real-time oxidative respiration after 
doxycycline pre-treatment.  
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Figure 2.12 Respiration rate curves for normal and Snell cells. 
(A) Respiration rate curves obtained with or without pre-treatment by doxycycline (0, 30, and 
60 ng/μl for 24 hours). Oxygen consumption rates in four different phases separated by 
injections of oligomycin, FCCP, and rotenone with antimycin A were measured for analysis of 
individual respiration parameters. Each line represents the average oxygen consumption rate 
for each group of N=6 mice; values for individual mice are shown by dark circles (normal) and 
light triangles (Snell). Horizontal lines (dark for normal, light for Snell cells) are shown across 
three graphs to serve as reference points for basal respiration levels in the absence of prior 
stress treatment. 
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We calculated the rates of total cellular respiration, respiration for ATP production, proton leak, 
and non-mitochondrial respiration by measuring oxygen consumption in four phases separated 
by injections of oligomycin, FCCP (carbonyl cyanide-4-trifluoromethoxy phenylhydrazone), and 
rotenone with antimycin A, which inhibit different components of ETC complex (Fig. 2.12; see 
methods for detailed information).  
At the basal level, where neither Snell nor normal cells had been pre-treated with doxycycline, 
the level of total respiration was similar, with Snell cells showing a slightly lower level that did 
not differ significantly (p=0.053) from normal controls (Fig. 2.13A). Further analysis comparing 
respiration rates before and after complex V (ATP synthase) inhibition by oligomycin revealed 
that oxygen consumption utilized for ATP production was 29% lower in Snell cells in the 
absence of prior doxycycline treatment (Fig. 2.13B). Doxycycline pre-treatment, however, 
lowered both total and ATP-synthesis-linked respiration normal cells, an effect to which Snell 
cells were resistant. After exposure to 60 ng/l doxycycline, Snell cells exceeded normal cells in 
both total (Fig 2.13A) and oligomycin-inhibited O2 consumption (Fig 2.13B). ATP-synthesis-
coupled respiration in normal cells pre-treated with 60 ng/μl doxycycline decreased 
approximately 70%, while the loss in respiration rate in Snell cells was only 30%. Thus, when the 
both normal and Snell cells had been pre-exposed to mitochondrial stress, respiration rate in 
Snell cells was resistant to the stress effect, and thus surpassed that in normal cells (Fig. 2.13A-
B, Fig. 2.12). 
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Spare respiration capacity was higher in normal fibroblasts when cells are not pre-exposed to 
doxycycline. Pre-exposure to 60 ng/ul doxycycline diminished spare respiration capacity in both 
normal and Snell fibroblasts. As noted previously, efficacy of doxycycline in inducing 
mitochondrial stress is similar in normal and Snell cells (Chap. 2.4; Fig 2.6). Nevertheless, in 
order to confirm that the maintenance of respiration rate in Snell cells was not due to 
inefficient mitochondrial stress induction, we calculated the level of mitochondrial stress-
induced proton leak. The level of initial damage induced by doxycycline, measured by proton 
leak-linked oxygen consumption, was ~12 x 10-12 moles/min in doxycycline-treated Snell cells 
and ~10 x 10-12 moles/min in normal cells, demonstrating that the efficacy of stress exposure on 
Snell cells was at least as high as on normal cells, if not higher (Fig. 2.13D).  
We saw no significant difference in non-mitochondrial respiration rates (Fig. 2.13E), confirming 
that the higher respiration rate in Snell cells was not due differences in non-mitochondrial 
factors such as cell size or cytosolic redox reactions. 
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Figure 2.13 Snell cells maintain mitochondrial function after stress.  
Real-time oxygen consumption rates were measured after pre-incubating cells in control media 
or media with 30 or 60 ng/μl doxycycline for 24 hours and individual respiration parameters 
were calculated. (A) Total respiration, (B) oxygen consumption linked to ATP production, (C) 
spare capacity, (D) proton leak, and (E) non-mitochondrial oxygen consumption. Mean values 
for fibroblasts from N=6 mice are shown for each group. Error bars represent SEM. (*) indicates 
p < 0.05 by Student’s t-test for comparison between normal and Snell cells.   
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2.8  Conclusions 
Primary fibroblasts from Snell dwarf mice are resistant to several forms of stress including 
paraquat, hydrogen peroxide, and cadmium exposure (Murakami et al., 2003). Here we show 
that Snell cells are also resistant to mitochondrial stress, specifically the effects of doxycycline 
on cell viability (Fig. 2.9), cellular ATP content (Fig. 2.10A), total oxidative respiration (Fig. 
2.13A), and rate of oxygen respiration linked to ATP synthesis (Fig. 2.13B). 
Increased mitochondrial stress resistance observed at the cellular level in Snell fibroblasts was 
consistent with higher mtUPR (HSP60 and LONP1) levels detected (Fig. 2.1, 2.2). Confirming 
previous findings (Page et al., 2009), analysis of mitochondrial protein levels (Fig. 2.3) and 
mtDNA content indicated that mitochondrial abundance was comparable in normal and Snell 
cells (Fig 2.4), suggesting that elevated expression levels of HSP60 and LONP1 in Snell 
fibroblasts cannot be explained by alterations in mitochondrial content, but indicate 
upregulation of mtUPR in fibroblasts isolated from long-lived Snell mice.  
In contrast to normal fibroblasts, Snell fibroblasts were able to maintain CoxI (mtDNA-encoded) 
transcript levels after inhibition of mitochondrial translation by doxycycline (Fig 2.5). 
Investigating this phenotype, we found that, in response to mitochondrial stress, upregulation 
of mitochondrial transcriptional factor Tfam was higher in Snell cells compared to normal cells, 
suggesting induction of mitochondrial transcription, which might have a role in maintenance of 
mtDNA-encoded CoxI transcript levels in Snell cells. In addition, Pgc-1α, the main regulator of 
mitochondrial biogenesis, was upregulated exclusively in Snell cells (Fig 2.7B). Snell-cell-specific 
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induction of PGC-1α was also detected at the protein level and was not specific to the agent 
used to induce mitochondrial stress (Fig 2.8). Taken together, our findings suggest that, in 
addition to mtUPR induction, Snell fibroblasts can also upregulate regulators of mitochondrial 
transcription and biogenesis, which may facilitate mitochondrial damage repair in cases where 
mtUPR upregulation is not sufficient (see discussion). 
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2.9  Materials and methods 
2.9.1 Mice 
Snell dwarf and littermate control mice were produced by crossing (DW/J x C3H/HeJ) Pit1dw/+ 
heterozygous parents. Snell mice with dw/dw genotype were identified by their small size at 
the age of 3 weeks. Heterozygotes and +/+ mice, which are not distinguishable phenotypically, 
were used as normal littermate controls. The mice were housed in microisolator cages with 
1/8” Bed-O-Cob bedding (The Andersons, Maumee, OH). The mice had free access to tap water 
and Purina 5001 Rodent Chow (St. Louis, MO). Snell mice were caged with normal sized females 
to prevent premature death from hypothermia. All experiments were performed in accordance 
with guidelines and regulations provided by the University of Michigan University Committee 
on Use and Care of Animals.  
2.9.2 Primary fibroblast cell culture 
Tail snips (~5 mm) were taken from 6-month-old Snell mice and normal siblings, washed with 
ethanol twice, and rinsed in PBS. Growth media (GM) was prepared by supplementing DMEM 
(Gibco, 11965-092) with 10% FBS and 1% penicillin/streptomycin (Gibco, 15140-122), resulting 
in a final concentration of 100 units/ml penicillin and 100 μg/ml streptomycin. Fibroblast 
isolation media (FIM) was prepared by dissolving Collagenase Type II (Gibco, 17101-015) in GM 
(400 U/ml), and sterilized by passing through a 0.2 μm filter. Individual tail snips were 
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transferred into 60 mm petri dishes containing a few drops of FIM, and minced using sterile 
scalpels to produce pieces smaller than 1 mm on each side. 4 ml of FIM was added to each dish, 
and minced tails were incubated 24 hours at 37 °C, 10% CO2. After incubation, the media with 
minced tail pieces was pipetted up and down several times, passed through sterile nylon 
netting (100 μm) to remove larger pieces, and centrifuged at 1000 g for 3 minutes. Supernatant 
was removed. The cells were re-suspended in 10 ml GM, seeded on 10 cm cell culture dishes 
and incubated at 37 °C, 10% CO2. When confluent, the cells were transferred to 15 cm dishes. 
After no more than 3 weeks of growth, primary fibroblasts were used for experiments.  
2.9.3 Mitochondrial stress treatments for protein and mRNA analysis 
The cells were counted and seeded on cell culture dishes (106 cells in 10 ml media per 10 cm 
dish) in GM. After 6 hours, GM was removed and replaced with cell media (CM; serum-free 
DMEM with no antibiotic). The next day, CM was removed and replaced with fresh CM 
containing either 30 μg/ml doxycycline (Santa Cruz, sc204734), 50 μg/ml thiamphenicol 
(Millipore Sigma, T0261), or an equal volume of diluent as control. The cells were incubated at 
37 °C, 10% CO2 for time intervals indicated for each experiment. For treatments longer than 24 
hours, the medium was replaced every day with fresh CM containing the compound of interest. 
At the end of treatment, the medium was removed. Cells were carefully washed with PBS, 
scraped, collected in 1 ml cold PBS, transferred to microcentrifuge tubes, and centrifuged for 3 
minutes at 1000 x g at 4 °C to remove PBS. Cell pellets were used for protein or RNA extraction. 
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2.9.4 Measurement of cell viability and lethal dose 50 (LD50) 
For cell viability assays, cells were seeded on 96-well cell culture plates (30 x 103 cells in 100 μl 
medium per well) in GM. After a 6-hour incubation, GM was replaced by CM. The next day, the 
medium was removed and CM containing doxycycline at the indicated concentrations was 
added. After 72 hours, WST-1 Cell Proliferation Reagent (Millipore Sigma, 05015944001) was 
added (10 μl/well), and the plate was incubated for 4 hours. Absorbance at λ = 440 nm was 
measured using a microplate spectrophotometer. The lethal dose 50 (LD50), i.e. the doxycycline 
dose corresponding to 50% decrease in formazan dye signal (produced by metabolically active 
cells) compared to untreated controls, was calculated.  
2.9.5 Measurement of cellular ATP content 
For ATP content measurements, primary fibroblasts were seeded (30 x 103 cells in 100 μl media 
per well) in a 96-well plate. Opaque-walled cell culture plates were used to prevent 
luminescence cross-talk between wells. After 6-hour incubation in GM, the medium was 
removed and replaced with CM. Cells were incubated overnight in CM. The next day, the 
medium was removed and CM containing doxycycline or rotenone (Millipore Sigma, R8875) at 
the indicated concentrations was added. After 72-hour incubation, ATP content was measured 
using a CellTiter-Glo® Assay Kit (Promega, G7571) as described in the product protocol. 
Luminescence signal was measured on a SynergyTM HT Multi-Mode Microplate Reader 
(BioTek® Instruments, Inc). All incubations were performed at 37 °C, 10% CO2. 
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2.9.6 Measurement of real-time oxidative consumption 
Real time measurement of oxygen consumption rates was performed using the XF Cell Mito 
Stress Test Kit (Agilent Technologies, 103015-100), XF FluxPak mini cartridge pack (Agilent 
Technologies, 102601-100), and XF Base medium (Agilent Technologies, 102353-100). Cells 
were seeded (104 cells in 200 μl GM per well) on a 96 well XF cell culture plate. After 6 hours, 
GM was replaced with CM and the cells were incubated overnight. The next day CM was 
removed and CM containing 0, 30, or 60 μg/ml doxycycline was added to induce mitochondrial 
stress. The cells were incubated for 24 hours at 37 °C, 10% CO2. In parallel, the sensor cartridge 
was placed in a utility plate (Agilent Technologies, 102601-100) containing 200 μl/well XF 
Calibrant (Agilent Technologies, 102601-100) and incubated overnight at 37 °C in non-CO2 
incubator for hydration. The next day, assay medium (AM) containing 1 mM pyruvate, 2 mM 
glutamine, and 10 mM glucose in XF Base medium was freshly prepared. AM was warmed to 37 
°C, adjusted to pH of 7.4 with 0.1 N NaOH, and sterilized by filtering. Cells were washed with 
AM by discarding 175 μl of 200 μl media and adding 175 μl AM three times, to prevent cell 
disruption. After the wash, 175 μl media was removed and 150 μl AM was added, leaving 175 μl 
AM in each well. Cell were examined under a microscope to make sure they were not detached 
during washes. The cells were incubated at 37 °C in a non-CO2 incubator for 45 minutes. In 
parallel, oligomycin (8 μΜ), FCCP (9 μΜ), and rotenone/antimycin A (5 μΜ) solutions were 
prepared in AM and loaded to cartridge ports A, B, and C respectively (25 μl per port). The 
cartridge with the utility plate was placed in a Seahorse XFe96 Extracellular Flux Analyzer 
(Agilent Technologies), and calibration was started. At the end of 45-minute incubation, the 
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utility plate in the XFe96 Extracellular Flux Analyzer was replaced with the cell plate and the 
measurement protocol was started. The operating software Wave (Agilent Technologies) was 
programmed in advance to perform measurements every ~6 minutes, injecting 25 μl oligomycin 
solution (final 1 μΜ) at t=28 min, 25 μl FCCP solution (final 1 μΜ) at t=47 min, and 25 μl 
Rotenone/Antimycin A solution (final 0.5 μM) at t=66 minutes. Oxygen consumption rate at 
each time point was calculated by Wave software according to readings collected from the 
XFe96 Extracellular Flux Analyzer. Each data point is the average of 5 technical replicates.  
2.9.7 Calculation of respiration parameters  
Respiration parameters were calculated by analyzing real-time oxygen consumption rate (OCR) 
measurements in four phases separated by injections of oligomycin, FCCP, and 
rotenone/antimycin A, which inhibit or activate specific pathways allowing the dissection of 
individual components of respiration. Total respiration is the oxygen consumption rate 
measured before the addition of oligomycin. 
Total Respiration = OCRt=27’ 
Respiration for ATP production was calculated by subtracting the oxygen consumption rate 
after inhibition of ATP synthase (ETC complex V) by oligomycin, the oxygen consumption that is 
not linked to ATP production, from total respiration rate 
Respiration for ATP production = OCRt=27’ - OCRt=46’ 
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Non-mitochondrial respiration is the reading after the mitochondrial ETC is totally blocked by 
addition of complex I/III inhibitors rotenone and antimycin A. 
Non-mitochondrial Respiration = OCRt=85’ 
Total mitochondrial respiration is calculated by subtracting non-mitochondrial respiration from 
total cellular respiration. 
Total mitochondrial respiration = OCRt=27’ - OCRt=85’ 
Proton leak was calculated by subtracting respiration for ATP production from total 
mitochondrial respiration: 
Proton Leak = [OCRt=27’ - OCRt=85’] – [OCRt=27’ - OCRt=46’] = OCRt=46’ - OCRt=85’ 
2.9.8 Western blot and antibodies 
Cell pellets were lysed in 200 μl RIPA buffer with protease inhibitor cocktail (ThermoFisher, 
78430) by incubating on ice for 20 minutes, vortexing every five minutes for 5 seconds each 
time. The lysates were centrifuged for 20 minutes at 8000 x g at 4 °C. The supernatants were 
collected in new tubes. Protein concentration was estimated using BCA Protein Assay 
(ThermoFisher, 23225) and adjusted accordingly. Laemmli protein sample buffer (BioRad, 161-
0747) containing β-mercaptoethanol (1.42 M) was added. Samples were incubated for 5 
minutes at 100 °C, cooled to room temperature, run on polyacrylamide gel, and transferred to 
PVDF membranes. The membranes were blocked with 2% bovine serum albumin (BSA) in TBST 
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solution (20 mM Tris, 500 mM sodium chloride, 0.9 mM polyoxyethylene-20-sorbitan 
monolaurate in deionized water), probed with primary antibodies β-Actin[C4]-HRP (Santa Cruz, 
sc47778HRP), PGC-1α (Millipore, ST1202), HSP60 (Santa Cruz, sc1052), or LONP1 (Abcam, 
ab103809) at 1:1000 dilution and incubated for 18 hours at 4 °C with shaking. Mitochondrial 
ETC proteins ATP5A, and UQCRC2 were detected using MitoProfile® Total OXPHOS Rodent WB 
Antibody Cocktail (Abcam, ab110413). Mouse IgG-HRP (Santa Cruz, sc2031), goat IgG-HRP 
(Santa Cruz, sc2350), and rabbit IgG-HRP (Cell Signaling, 7074S) were used as secondary 
antibodies at 1:2000 dilution. The membranes were incubated with secondary antibodies on a 
shaker for 90 minutes at room temperature. After primary and secondary incubations, the 
membranes were washed three times in TBST for 10 minutes each time to minimize non-
specific binding. Protein bands were detected using enhanced chemiluminescent substrate 
(ThermoFisher, 34075) and a chemiluminescence imager. Signal strength was quantified using 
ImageJ software. 
2.9.9 mRNA extraction and q-rtPCR 
Frozen cell pellets were lysed in 1 ml TRIzol reagent (ThermoFisher) by sonication on ice for 30 
seconds with 1 second on/off cycles. The lysates were transferred to pre-cooled Phase Lock 
Gel-Heavy tubes. Chloroform (0.2 ml for 1 ml TRIzol) was added. After 3 minutes of incubation 
at room temperature, the tubes were centrifuged for 15 minutes at 7500 x g at 4 °C. Aqueous 
phase (~0.5 ml) was transferred to new tubes. Isopropanol (0.5 ml) was added. After 10 
minutes of incubation at room temperature, the RNA was precipitated by centrifugation at 
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7500 x g at 4 °C. The supernatant was discarded. The precipitated RNA was washed with 75% 
ethanol (1 ml), and then centrifuged for 5 minutes at 7500 x g at 4 °C. The supernatant was 
carefully discarded. Precipitated RNA was air-dried and resuspended in 50 μl RNase-free water. 
RNA concentration was measured by nanodrop. cDNA was produced by iScript cDNA Synthesis 
Kit (BioRad, 1708890) according to the protocol provided by the manufacturer. qPCR was 
performed using Fast SYBRTM Green Master Mix (ThermoFisher, 4385612) according to product 
protocol. The primers are listed below in the format described on the first row: 
 [Gene], [PubMed Gene ID], [Forward primer sequence], [Reverse primer sequence].  
 Hsp60, 15528, tgtttggagaagaggggttg, cgctcgttcagcttttcttt. 
 Hsp10, 15528, gggtcaggagggaaaggaaa, cagcttcacgtgacaccatt. 
 Lonp1, 74142, tggttgagctcctgagaagg, aacttgtctccgaggtcctg. 
 Vdac1, 22333, agaggtacagcagaaacccc, aggtgtgtacatgcttccga. 
 Pgc-1α (Ppargc1a), 19017, atgtgtcgccttcttgctct, atctactgcctggggacctt. 
 Tfam, 21780, agccaggtccagctcactaa, aaacccaagaaagcatgtgg.  
 CoxI (mt-Co1), 17708, tcatcccttgacatcgtgct, gtctgagtagcgtcgtggta.  
 Cox4i (Cox4i1), 12857, ccatgtcacgatgctgtctg, ctcccaaatcagaacgagcg. 
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2.9.10 Statistical analysis 
Prism (GraphPad Software, Inc) was used for statistical analysis and graphical representation of 
the data. Error bars represent SEM. Comparisons between groups were performed using 
Student’s t-test. For experiments involving more than one variable, two-way ANOVA was used 
to analyze individual effects of and interaction between the two factors. Differences with p 
values smaller than 0.05 were considered significant.  
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Chapter 3 -  Mitochondrial stress response and ETC proteostasis in Snell mice  
3.1  Introduction 
Mouse lifespan can be extended both by genetic alterations and by post-natal treatments 
(Flurkey et al., 2010; Miller et al., 2005; L. Sun, Sadighi Akha, Miller, & Harper, 2009). Snell mice, 
one of the most studied long-lived mouse models, have a single point mutation in Pit1, and 
show more than 40% increase in mean and maximal lifespan (Flurkey et al., 2001) (see section 
1.1.3.1). Negative effects of the Pit1 mutation on growth hormone (Wilson & Wyatt, 
1986b)(Sinha, Salocks, & Vanderlaan, 1975), prolactin (Wilson & Wyatt, 1986b), thyroid-
stimulating hormone (Wilson & Wyatt, 1986a), and IGF-1 signaling (van Buul-Offers et al., 1994) 
are well established in Snell mice. However, how these alterations result in prolonged lifespan 
and delayed onset of aging-associated pathologies remains elusive.  
Upregulation of the mitochondrial stress response (mtUPR) has been proposed as a common 
longevity mechanism linking mitochondrial disruption to longevity (Houtkooper et al., 2013). 
Mitochondrial stress applied early in life by temporary silencing of cytochrome c oxidase-1 
subunit Vb/COX4 (cco-1), which results in lifespan extension in C. elegans, also causes mtUPR 
(hsp6) upregulation that persists throughout the lifespan long after withdrawal of the initial 
stress (Durieux et al., 2011). Maintenance of hsp6 upregulation after transient exposure to 
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mitochondrial stress indicates that nematode mtUPR pathway can be rewired permanently 
during larva stages. Transgenic worms with muscle-specific overexpression of nematode mtUPR 
protein Hsp70F live more than 40% longer, implying that mtUPR upregulation may be sufficient 
for lifespan extension in worms (Yokoyama et al., 2002). Overall, accumulating data from 
studies in C. elegans suggest a prolongevity role for mtUPR upregulation.  
Mclk1 is the mouse orthologue of the C. elegans gene clk-1, which encodes a mitochondrial 
enzyme involved in ubiquinone biosynthesis. Although the homozygous deletion of Mclk1 in 
mice is lethal (Levavasseur et al., 2001), mice heterozygous for Mclk1 show prolonged average 
and maximum lifespan, suggesting evolutionary conservation of this longevity pathway. No data 
are available on the levels of mtUPR in Mclk1+/- mice. It is likely that decreased expression of 
Mclk-1 induces mtUPR, since Mclk1+/- mice show reduced mitochondrial electron transport and 
ATP synthesis, indicating mitochondrial defects (Lapointe & Hekimi, 2008). Mice with deleted 
Surf1, a putative ETC complex IV gene, also live longer (Dell'agnello et al., 2007), suggesting that 
sublethal defects in mitochondrial proteome may induce lifespan extension not only in worms 
but also in mammals.  
In the previous chapter, we presented data demonstrating that primary fibroblasts isolated 
from long-lived Snell mice exhibit elevated levels of basal and induced mtUPR. In addition, 
cellular ATP content, and oxidative respiration rate is maintained in Snell cells after 
mitochondrial stress exposure, suggesting improved resistance to mitochondrial stress. 
101 
 
Fibroblasts from long-lived Surf1-/- mice also show elevated mtUPR (Pharaoh et al., 2016). 
However, it is not known whether mtUPR is elevated in vivo in any long-lived mouse model.  
In this work, in order to examine whether the mtUPR is elevated in Snell mice, we assess 
hepatic mtUPR and mito-nuclear protein stoichiometry in normal and Snell mice after 2-week 
of in vivo doxycycline treatment. Since our work suggested a rewiring in the mitochondrial 
biogenesis pathway in Snell mice, we also evaluated Tfam and Pgc-1α expression.  
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3.2  Mitochondrial biogenesis pathway is constitutively upregulated in Snell liver 
Our finding that Snell fibroblasts have elevated expression of Tfam and Pgc-1α suggested that 
components of the mitochondrial biogenesis pathway may have altered regulatory mechanisms 
in Snell mice. To assess in vivo gene expression, we measured Tfam and Pgc-1α mRNA levels in 
liver tissue samples from normal and Snell mice. First, we monitored mRNA levels of three 
independently regulated genes encoding mitochondrial proteins to test if Snell liver shows a 
general alteration in transcript levels of genes associated with mitochondrial function. Vdac1 
(Porin) encodes a mitochondrial transport channel protein which is widely used as a 
mitochondrial loading control. Cox4i encodes a nuclear-DNA-encoded ETC protein, and CoxI 
encodes a mitochondrial-DNA-encoded ETC protein. We did not find any difference in the 
mRNA levels of nDNA encoded Vdac1 or Cox4i, or in mtDNA encoded CoxI (Fig. 3.1A).  
In contrast to comparable mRNA levels of Vdac1, CoxIVi, and CoxI, we observed a small but 
significant elevation in Tfam expression (~1.5-fold, p=0.03) in Snell liver. Intriguingly, compared 
to normal mice, we detected a dramatic upregulation of Pgc-1α expression (5±2-fold, p<0.001) 
in the liver of Snell mice (Fig. 3.1B). We further confirmed this result by performing an 
independent experiment with an additional set of mice comprising both sexes and noted that 
the phenotype was not gender specific; Pgc-1α expression was also elevated in female Snell 
mice (Fig. 3.1C). In addition, we found elevated levels of TFAM and PGC-1α protein in Snell liver 
(Chap. 4.4; Fig. 4.2A, B). Previously, PGC-1α protein has been reported to be elevated in the 
liver of long-lived GHR-KO mice (Al-Regaiey, Masternak, Bonkowski, Sun, & Bartke, 2005).  
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Figure 3.1 Tfam and Pgc-1α expression are constitutively upregulated in Snell liver.  
(A) mRNA levels of Vdac1, Cox4i, Cox1, and (B) Tfam and Pgc-1α in the liver tissue of normal 
and Snell mice (N=6, males). Mean values are shown. Error bars represent SEM. (C) Pgc-1α 
transcript levels in the liver tissue of an independent set of normal and Snell mice of both 
genders (N=6). Normal mice are represented by dark circles; Snell mice are represented by light 
triangles. Horizontal bars represent the mean for each group. (*) indicates p < 0.05 by Student’s 
t-test for comparison between normal and Snell mice.  
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3.3  Acute mitochondrial stress does not cause weight loss 
Acute doxycycline treatment of mice has been shown to disturb mitochondrial protein 
stoichiometry in liver by decreasing the ratio of mtDNA-encoded respiratory chain proteins to 
those encoded in the nuclear DNA (Moullan et al., 2015). We exposed normal and Snell mice to 
in vivo mitochondrial stress by feeding them a doxycycline diet for two weeks. Following the 
treatment, we assessed the level of mtUPR induction and maintenance of mito-nuclear protein 
balance as indicators of mitochondrial stress response and protection against mitochondrial 
stress at the organismal level (Fig. 3.2). We did not detect any effect on food consumption or 
change in body weight in normal or Snell mice (Fig. 3.3).  
Figure 3.2 In vivo doxycycline treatment. 
Normal and Snell young adult (6-month-old) mice were exposed to acute mitochondrial stress 
by in-vivo doxycycline treatment for two-weeks (N=6 mice per group). Weight measurements 
were taken on days indicated in the figure. Dissections were performed on day 15. Mice were 
not fasted prior to dissection.  
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Figure 3.3 Doxycycline diet does not affect body weight of normal or Snell mice. 
Body weight of each mouse on indicated days of the treatment period. Normal mice are 
represented by dark lines; Snell mice are represented light lines. Mice fed on doxycycline diet 
are represented by dashed lines.  
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3.4  Hepatic mtUPR induction is higher in Snell liver  
In our cell culture studies, we noted elevated levels of HSP60 and LONP1 in primary fibroblasts 
from Snell mice, independent of mitochondrial stress exposure (Chap. 2.2; Fig. 2.1, 2.2). As 
opposed to our findings in Snell fibroblasts, HSP60 and LONP1 protein levels (basal mtUPR) in 
liver were comparable in normal and Snell mice on the control diet (Fig. 3.4A-C, control diet).  
However, when the mice were exposed to acute mitochondrial stress by in vivo doxycycline 
treatment, both HSP60 (Fig. 3.4B) and LONP1 (Fig. 3.4C) protein levels were higher in Snell liver 
samples. Average HSP60 induction in response to doxycycline-mediated mitochondrial stress 
was 2.9% in normal mice and 54.3% in Snell mice (p=0.01); average LONP1 induction was 12.6% 
in normal mice and 57.2% in Snell mice (p=0.02) (Fig. 3.4D).  
Overall, our results demonstrate that the basal mtUPR levels in Snell liver tissues are 
comparable to those in normal liver, while the average mtUPR induction in response to the 
doxycycline treatment is much higher in Snell livers.  
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Figure 3.4 Higher mtUPR induction in Snell liver 
 (A) HSP60 and LONP1 protein blots for liver tissue samples from normal and Snell mice. (B) 
Basal and induced levels of HSP60 and (C) LONP1 protein expression. (D) Level of HSP60 and 
LONP1 induction (mtUPR induction) in response to mitochondrial stress exposure. Mean values 
for each group are shown (N=6). Error bars represent SEM. (*) indicates p < 0.05 by Student’s t-
test for comparison between normal and Snell mice. Results of two-factor ANOVA are shown in 
the boxed inset, with p-values for the Interaction (“Int.”) effects.  
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3.5  Effect of in vivo mitochondrial stress on mitochondrial ETC protein stoichiometry  
To determine whether Snell mice were resistant to disruption of mitochondrial electron 
transport chain (ETC) protein stoichiometry, we measured protein levels of COXI, a 
mitochondrial-DNA-encoded subunit of ETC complex IV, and ATP5A, nuclear-DNA-encoded 
subunit of ETC complex V, in liver tissues of normal and Snell mice (Fig. 3.5A). Because 
doxycycline inhibits mitochondrial translation without affecting cytosolic translation, we 
expected to observe a decrease in COXI levels, with no effect on ATP5A levels. Inhibition of 
COXI expression would result in a decrease in COXI/ATP5A ratio, resulting in an imbalance 
between mtDNA- and nDNA- encoded ETC proteins in the mitochondria.  
In the absence of doxycycline treatment, COXI/ATP5A ratios were comparable in normal and 
Snell mice, with no indication of an alteration in ETC stoichiometry in Snell mice (Fig. 3.5B-C, 
mice on control diet). As predicted, doxycycline treatment inhibited COXI expression in the liver 
(Houtkooper et al., 2013), but disturbance of ETC protein stoichiometry was weaker in Snell 
mice. Average COXI/ATP5A ratio was 0.62 in normal and 0.80 in Snell livers.  
ATP5A is a subunit of ATP synthase (complex V) which differs from the other four complexes 
(see chap. 1.2.3 Respiratory Chain). As electron transport can be uncoupled from ADP 
phosphorylation, expression of ATP synthase subunits can be regulated independent of 
complexes I-IV. Mouse brown fat, for example, shows low ATP synthase levels, despite high 
abundance of mitochondrial mass and presence of a proton gradient generated by electron 
transport chain complexes I-IV (Lindberg et al., 1967). To rule out an ATP synthase-specific 
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effect of doxycycline treatment, we also assessed protein levels of UQCRC2, a subunit of ETC 
complex III, and calculated the COXI/UQCRC2 ratio as an additional measure of mito-nuclear 
protein balance.  
As in the case of COXI/ATP5A, we did not detect a difference in COXI/UQCRC2 protein ratios 
between normal and Snell livers in mice fed on control diet. However, in doxycycline treated 
mice, COXI/UQCRC2 ratio was 0.61 in normal and 0.95 in Snell livers. Of note, the weaker 
disruption observed in Snell mice was not due to lower efficacy of mitochondrial stress 
treatment since the induced mtUPR was higher in Snell liver both at protein (Fig. 3.4) and 
mRNA levels (Fig. 3.6). Our findings suggest that, after two-week mitochondrial stress exposure, 
ETC protein stoichiometry is preserved better in Snell liver than in normal liver.  
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Figure 3.5 Mito-nuclear protein stoichiometery in Snell liver 
Liver tissues of normal and Snell mice were analyzed to assess mito-nuclear protein 
stoichiometry after two-week in vivo doxycycline treatment. (A) Mitochondrial-DNA-encoded 
COX1, and nuclear-DNA-encoded ATP5A and UQCRC2 protein blots, and (B) mito-nuclear 
protein balance measured by COX1/ATP5A and (C) COX1/UQCRC2 ratios for normal and Snell 
liver samples from mock and doxycycline-treated mice. Mean values for each group are shown 
(N=6). Error bars represent SEM. (*) indicates p < 0.05 by Student’s t-test for comparison 
between normal and Snell cells.  
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Figure 3.6 Higher levels of induced Hsp60 mRNA expsression in Snell liver.  
Liver tissues of normal and Snell mice were analyzed by qPCR to assess Hsp60 gene expression 
after two-week in vivo doxycycline treatment. Normal mice are represented by dark circles; 
Snell mice are represented by light triangles. Horizontal bars represent the mean for each group 
(N=6). (*) indicates p < 0.05 by Student’s t-test for comparison between normal and Snell mice.  
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3.6  Conclusions 
In cell culture, only Snell fibroblasts show Pgc-1α upregulation in response to mitochondrial 
stress (Fig. 2.7B). In order to test whether Pgc-1α expression was altered in vivo, we analyzed 
liver tissues from Snell and normal mice without mitochondrial stress exposure, and found that 
Pgc-1α mRNA levels are constitutively upregulated in the livers of Snell mice. Pgc-1α transcript 
levels in Snell liver samples were 5-10 fold higher than those in normal controls (Fig. 3.1B), 
independent of sex (Fig. 3.1C). Expression of Tfam, another indicator of mitochondrial 
biogenesis, was also upregulated in Snell liver. Although upregulation of Tfam and Pgc-1α may 
imply increased mitochondrial biogenesis in Snell mice, further experiments are required to test 
this suggestion.  
As noted in the previous chapter, compared to those in normal fibroblasts, levels of the mtUPR 
proteins HSP60 and LONP1 were higher in Snell fibroblasts even in the absence of 
mitochondrial stress exposure, indicating elevated levels of basal mtUPR in Snell fibroblasts in 
cell culture (Fig. 2.1, 2.2). To assess mtUPR in-vivo, we exposed normal and Snell mice to 
mitochondrial stress by doxycycline treatment. 
In contrast to our findings in fibroblasts, basal mtUPR levels in liver were comparable in normal 
and Snell mice fed on the control diet. However, in response to doxycycline treatment, Snell 
mice showed stronger mtUPR induction. Upon mitochondrial stress exposure, the increase in 
protein levels of HSP60 and LONP1 was 50-60% in Snell liver, and only 2-15% in normal mice 
(Fig. 3.4D). Importantly, disruption of respiratory chain protein stoichiometry as measured by 
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the alteration in the ratio of mtDNA-encoded COXI to nDNA-encoded ATP5A and UQCRC2 was 
5-20% in Snell mice and 40% in normal mice (Fig 3.5). Stronger mtUPR induction in Snell liver 
accompanied by indications of improved maintenance of mito-nuclear protein balance in Snell 
liver suggests that Snell mice may have an improved capacity to respond to mitochondrial 
stress and, in turn, experience lower mitochondrial damage.  
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3.7  Materials and methods 
3.7.1 Mice 
Snell dwarf and littermate control mice were produced and housed as explained in Chap 2. The 
mice were either euthanized for tissue collection or used in doxycycline treatment experiments 
at the age of 6 months. All experiments were performed in accordance with guidelines and 
regulations provided by the University of Michigan University Committee on Use and Care of 
Animals. 
3.7.2 In vivo doxycycline treatment 
6-month-old male Snell mice (N=6) and normal siblings (N=6) were fed control (BioServ, S4207) 
or doxycycline chow (BioServ, S3888), corresponding to 50 mg per kg body weight per day 
doxycycline intake. Weight measurements were taken on days 0, 2, 5, 10, and 14 of doxycycline 
treatment. The mice were dissected on day 15, without a period of fasting prior to euthanasia. 
Liver tissue samples were collected and frozen in liquid nitrogen. Frozen tissue samples were 
reduced to powder using a mortar and pestle, and stored at -80 °C.  
◦ ◦ ◦ 
Western blot analysis, mRNA extraction, and q-rtPCR were performed as explained in Chap 2; 
instead of cell pellets, powdered tissue samples were used to prepare samples. Methods for 
mice generation and husbandry and statistical analysis were presented in Chap 2. 
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Chapter 4 -  N6-methyladenosine-mediated cap-independent translation in long-lived 
Snell dwarf mice 
4.1  Introduction 
Several long-lived mouse models including rapamycin treated mice, GHR-KO mice (Dominick et 
al., 2015), Ames mice (Sharp & Bartke, 2005), and Snell mice (Dominick et al., 2015) show 
reduced mTORC1 signaling, which results in a decrease in 4E-BP1 phosphorylation, leading to 
suppression of canonical cap-dependent translation (see section 1.1.5.2 for details). Despite a 
general decline in protein synthesis, cells with diminished mTORC1 activity still exhibit 
upregulated levels of certain proteins functioning in pathways critical for survival such as 
maintenance of DNA integrity (Dominick, Bowman, Li, Miller, & Garcia, 2017), proteostasis 
(Pickering et al., 2015), and autophagy (M. Wang & Miller, 2012a).  
Dr. Garcia from our group recently reported that two proteins involved in DNA damage repair, 
NDRG1 and MGMT, exhibit elevated protein levels in Snell liver without a detectable increase in 
corresponding mRNA levels (Dominick et al., 2017). During our investigation of mtUPR in Snell 
mice, we observed a similar phenomenon where elevated levels of mtUPR protein LONP1 and 
mitochondrial biogenesis proteins TFAM and PGC-1α in Snell cells and tissues were often not 
accompanied by comparable increases in corresponding mRNA levels. While upregulation of 
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protein expression without an alteration in mRNA levels implies regulation of protein 
expression at translational level, it is not clear how translation of certain transcripts are 
promoted in Snell mice despite an overall decline in cap-dependent translation.  
Recently, a new mechanism for cap-independent translation initiation has been described, 
where mRNA transcripts bearing a 5’UTR motif with N6-methyladenosine modification are 
selectively translated (N6-methyladenosine-mediated cap-independent translation; m6A-CIT) 
(Linder et al., 2015; Meyer et al., 2015; X. Wang et al., 2015; J. Zhou et al., 2015). In essence, 
two methyltransferases, METTL3 and METTL14, preferentially methylate adenosine residues 
found in DRACH (D=A/G/U; R=G/A; H=A/C/U) motifs located in 5'UTR mRNA regions to form N6-
methyladenosine. The demethylases FTO and ALBH5 can remove the N6-methyladenosine 
modifications. YTHDF proteins promote translation of m6A-bearing mRNAs (see section 1.3 for 
details).  
We hypothesized that the aforementioned proteins found to be upregulated in long-lived Snell 
mice are synthesized through m6A-CIT, and that m6A-CIT is elevated in Snell mice. To test our 
hypothesis, we investigated whether (i) protein expression of NDRG1, MGMT, TFAM, PGC-1α, 
and LONP1 are regulated by m6A-CIT, and (ii) m6A-CIT translation pathway is elevated in Snell 
mice, i.e. the expression of m6A-CIT promoting proteins, m6A "writers" METTL3/14 and m6A 
"readers" YTHDF1/2, are upregulated relative to m6A-CIT impeding proteins, m6A "erasers" 
ALKBH5 and FTO.  
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4.2  NDRG1, MGMT, TFAM, PGC-1α, and LONP1 are upregulated in Snell fibroblasts 
without comparable increases in corresponding transcript levels 
In a collaborative effort with Dr. Garcia, we performed a detailed analysis of protein and mRNA 
expression levels of Ndrg1, Mgmt, Tfam, Pgc-1α, and Lonp1. We found higher protein levels of 
NDRG1 in Snell fibroblasts despite lower mRNA levels. MGMT protein levels in Snell cells were 
~5 fold higher than those in normal cells, while Mgmt transcript levels were 1.3-fold higher in 
Snell cells. Mitochondrial protease LONP1 protein levels higher in Snell cells, despite 
comparable mRNA expression in normal and Snell cells. TFAM and PGC-1α were upregulated in 
Snell cells only at protein level. Average transcript levels of Tfam and Pgc-1α were lower in Snell 
cells, but the differences were not significant (p=0.07 and p=0.2, respectively).  
Overall, four out of five genes analyzed showed elevated protein levels in Snell cells without a 
parallel increase in corresponding transcript levels. Although we detected higher mRNA levels 
(1.3-fold) of Mgmt in Snell cells, difference in corresponding protein levels (5-fold) were much 
higher. 
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Figure 4.1 NDRG1, MGMT, LONP1, TFAM, and PGC-1α protein and mRNA expression levels in 
primary fibroblasts isolated from normal and Snell mice.  
Primary fibroblasts from normal and Snell mice were analyzed for protein and mRNA levels. (A) 
Protein blots of NDRG1, MGMT, LONP1, TFAM, PGC-1α, and β-ACTIN for control are shown. (B) 
Protein, and (C) mRNA levels normalized to corresponding expression levels found in normal 
fibroblasts for each gene. Mean values are shown for each group (N=6). Error bars represent 
SEM. (*) indicates p < 0.05 by Student’s t-test for comparison between normal and Snell 
fibroblasts.  
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4.3  NDRG1, MGMT, TFAM and LONP1, but not PGC-1α, are upregulated in Snell liver 
without comparable increases in corresponding transcript levels  
Previously we found that NDRG1 and MGMT protein levels are elevated in Snell liver, but no 
significant alteration was detected in corresponding mRNA levels (Dominick et al., 2017). In this 
prior study, mice were fasted 18 hours before dissection. We asked whether LONP1, TFAM, and 
PGC-1α also exhibit a similar pattern in Snell liver under these conditions (Fig. 4.2A).  
We found that expression of the mitochondrial protease LONP1 was 3-4-fold higher in Snell 
liver, while elevation in Lonp1 mRNA levels was slightly less than 2-fold but the difference did 
not reach significance (p=0.1). TFAM protein levels were ~2 fold higher in Snell liver, while 
corresponding transcript levels were elevated 1.4 fold. In contrast, the difference in PGC-1α 
protein levels between Snell and normal samples was 1.5 fold, while the difference in mRNA 
levels was 3.4 fold, which differs from the pattern found in Snell fibroblasts and does not 
suggest translational regulation.  
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Figure 4.2 LONP1, TFAM, and PGC-1α protein and mRNA expression levels in liver of normal 
and Snell mice.  
Liver tissue samples from normal and Snell mice are analyzed for protein and mRNA levels. (A) 
Protein blots of LONP1, TFAM, PGC-1α, and β-ACTIN as control are shown. (B) Protein, and (C) 
mRNA levels normalized to corresponding expression levels found in normal fibroblasts for each 
gene. Mice were fasted 18-hours prior to dissection. Mean values are shown for each group 
(N=6). Error bars represent SEM. (*) indicates p < 0.05 by Student’s t-test for comparison 
between normal and Snell mice.  
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4.4  m6A-CIT regulates protein levels of NDRG1, MGMT, TFAM, and PGC-1α, but not of 
LONP1 
For all five genes investigated, we noted a marked discrepancy between mRNA and protein 
expression levels in fibroblasts or liver from Snell mice, suggesting an upregulation at the 
translational level. Analysis of 5'UTR mRNA sequences revealed that Ndrg1, Mgmt, Lonp1, 
Tfam, and Pgc-1α transcripts carried the consensus motif for m6A modification, making them 
putative targets of m6A-CIT (Linder et al., 2015; J. Zhou et al., 2015).  
METTL3 is one of the m6A "writer" proteins which adds N6-methyladenosine modifications on 
mRNA transcripts. Deletion of METTL3 leads to loss of m6A marks on target transcripts, and 
reduces their translation through m6A-CIT (Meyer et al., 2015; X. Wang et al., 2015). In order to 
assess whether NDRG1, MGMT, LONP1, TFAM, and PGC-1α protein levels are regulated by m6A-
CIT, we knocked-down METTL3 expression in HEK-293T cells, and performed western blot 
analysis.  
Cells transfected with shMETTL3 showed ~70% inhibition in METTL3 expression compared to 
cells transfected with control shRNA (Fig. 4.3A). Downregulation of m6A-CIT by METTL3 knock-
down resulted in a decrease in protein levels of NDRG1, MGMT, TFAM, and PGC-1α, confirming 
that these proteins were partly synthesized through m6A-CIT. Effect of METTL3 knock-down on 
PGC-1α expression (20% decrease) was weaker than its effect on NDRG1, MGMT, and TFAM 
expression (50-60% decrease). On the other hand, we did not detect an effect on β-ACTIN or 
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LONP1 protein levels. Accordingly, we ruled out LONP1, and confirmed NDRG1, MGMT, TFAM, 
and PGC-1α as targets of m6A-mediated cap-independent translation.  
 
 
 
Figure 4.3 Protein levels of NDRG1, MGMT, TFAM and PGC-1α, but not LONP1 decrease upon 
METTL3 knock-down.  
HEK 293 cells were transfected with control shRNA or shMETTL3 and analyzed for protein 
expression. (A) Representative protein blot. (B) Protein levels normalized to controls. Mean 
values for N=6 different transfections are shown. Error bars represent SEM. (*) indicates p < 
0.05 by Student’s t-test for comparison between control and METTL3 knock-out cells. 
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4.5  m6A-CIT pathway is upregulated in multiple tissues of Snell mice  
In the previous sections we presented data demonstrating elevated protein levels of NDRG1, 
MGMT, LONP1, TFAM, and PGC-1α in Snell fibroblasts without a comparable elevation in 
corresponding transcript levels (Fig. 4.1). A similar pattern was observed in Snell liver for 
NDRG1, MGMT (Dominick et al., 2017), LONP1, and TFAM (Fig. 4.2). We were able to confirm 
that protein levels of NDRG1, MGMT, TFAM, and PGC-1α, but not of LONP1 are regulated by 
m6A-CIT (Fig. 4.3). These findings suggested that m6A-CIT might play a role in upregulation of 
NDRG1, MGMT, TFAM, and to a lesser extent, of PGC-1α in Snell mice. Accordingly, we sought 
to assess whether proteins regulating the m6A-CIT pathway were differentially expressed in 
Snell mice (Fig. 4.4A).  
METTL3 and METTL14 methylate N6-adenosine residues residing in the 5’UTR of mRNA 
transcripts. We found that protein levels of m6A “writers”, METTL3 and METTL14, were ~80% 
elevated in liver of Snell mice, compared to those in normal controls (Fig. 4.4B). The transcripts 
bearing the 5’UTR m6A modifications are recognized by YTHDF1 and YTHDF2, which promote 
their translation via m6A-CIT. Both YTHDF1 and YTHDF2 protein levels were 3-4-fold higher in 
Snell liver (Fig. 4.4C). In contrast, protein levels of negative regulators of m6A-CIT, ALKBH5 and 
FTO, which remove m6A modifications from target transcripts, were either only ~20% higher 
(ALKBH5) in Snell liver or similar (FTO) in liver of Snell and normal mice (Fig. 4.4D).  
To further investigate this phenotype, we assessed protein expression levels of m6A-CIT 
regulators in kidney and skeletal muscle of Snell and normal mice. Protein levels of the m6A 
124 
 
“writer” METTL3 were 3-fold higher in Snell kidney samples (Fig. 4.5A). METTL14 expression 
was comparable in Snell and normal samples. The m6A “readers”, YTHDF1 and YTHDF2, were 
elevated 7-fold and 3-fold in Snell kidneys, respectively. Protein levels of the negative 
regulators of m6A-CIT, however, were either comparable (FTO) in kidneys of Snell and normal 
mice, or even lower (ALKBH5) in Snell mice. In skeletal muscle, we observed a very similar 
pattern, except one difference: both m6A “writer” proteins, METTL3 and METTL14, were 
elevated in Snell mice (Fig. 4.5B).  
Overall, in all three tissues tested, we observed elevated levels of m6A “writer” and “reader” 
proteins, which promote m6A-CIT, but either downregulated or unaltered levels of “eraser” 
proteins, which negatively regulate m6A-CIT. This protein expression pattern indicates that m6A-
CIT pathway is upregulated in long-lived Snell dwarf mice.  
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Figure 4.4 Elevated levels m6A writer and reader proteins in Snell liver.  
Liver protein expression in normal and Snell mice. (A) Protein blots for N=2 mice are shown. (B) 
Protein levels of m6A writers, (C) readers, and (D) erasers normalized to normal controls. Mice 
were fasted 18-hours prior to dissection. Mean values are shown for each group (N=6). Error 
bars represent SEM. (*) indicates p < 0.05 by Student’s t-test for comparison between normal 
and Snell mice. 
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Figure 4.5 Protein levels of m6A regulators in Snell kidney and skeletal muscle.  
Kidney and skeletal muscle tissue samples from normal and Snell mice were analyzed for 
protein expression. (A) Protein levels in kidney and (B) skeletal muscle tissue samples are 
shown normalized to normal littermate controls. Mice were fasted 18 hours prior to dissection. 
Mean values are shown for each group (N=6). Error bars represent SEM. (*) indicates p < 0.05 
by Student’s t-test for comparison between normal and Snell mice.  
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4.6  Conclusions 
In Snell fibroblasts, we noted elevated protein levels of NDRG1, MGMT, LONP1, TFAM, and 
PGC-1α (Fig. 4.1A, B). In contrast, corresponding mRNA levels were either lower than or 
comparable to those in normal controls (Fig. 4.1C). In vivo, similar to the expression pattern 
reported for the DNA repair proteins NDRG1 and MGMT (Dominick et al., 2017), we detected 
elevated protein levels of LONP1 and TFAM in Snell liver (Fig. 4.2A, B), without comparable 
increases in corresponding mRNA levels (4.2C). These observations suggested that protein 
expression of NDRG1, MGMT, LONP1, TFAM, and PGC-1α might be upregulated by a selective 
translation mechanism. 
Transcripts bearing 5'UTR N6-methyladenosine modifications can be translated by m6A-
mediated cap-independent translation (m6A-CIT). We found that that m6A "writers" METTL3 
and METTL14, which mark target mRNAs for m6A-CIT, and m6A "readers" YTHDF1 and YTHDF2, 
which recognize m6A marks and promote translation of m6A-tagged mRNAs, are upregulated in 
liver, kidney, and skeletal muscle of Snell mice. In contrast, m6A "erasers" ALKBH5 and FTO, 
which negatively regulate m6A-CIT by removing m6A marks, were either downregulated or not 
altered, indicating that elements that promote the m6A-CIT pathway are upregulated in tissues 
of Snell mice (Fig. 4.4, 4.5).  
The consensus motif which identifies putative targets of m6A-CIT is found in 5’UTRs of Ndrg1, 
Mgmt, Tfam, Lonp1, and Pgc-1α mRNAs. We tested whether the levels of corresponding 
proteins are regulated by m6A-CIT by knocking-down METTL3 in HEK 293 cells, and found that 
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protein levels of NDRG1, MGMT, and TFAM, but not of LONP1, are regulated by m6A-CIT (Fig. 
4.3).  
Our findings indicate that m6A-CIT is upregulated in long-lived Snell mice. In principle, 
upregulated m6A-CIT might partly account for the elevated levels of NDRG1, MGMT, TFAM, and 
PGC-1α in Snell mice, however, further experiments are required to verify this suggestion.  
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4.7  Materials and methods 
4.7.1 Mice 
Snell dwarf and littermate control mice were produced and housed as explained in Chap 2. The 
mice were fasted for 18 hours prior to dissection. All experiments were performed in 
accordance with guidelines and regulations provided by the University of Michigan University 
Committee on Use and Care of Animals. 
4.7.2 METLL3 knock-down  
HEK 293T cells were transfected with shMETLL3 or control shRNA (Sigma, SHCLNG-NM_019852) 
using Lipofectamine 3000 transfection reagent (ThermoFisher, L3000) as described in the 
protocol provided by the manufacturer. Cell were collected for protein analysis 96 hours after 
transfection. Knock-down was confirmed by western blot analysis of METTL3 expression which 
showed 70% decrease in METTL3 protein levels.  
4.7.3 Western blot and antibodies 
Western blot analysis was performed as explained in Chap2; instead of cell pellets, powdered 
tissue samples were used to prepare the samples. In addition to those listed in Chap 2, the 
membranes were probed with primary antibodies NDRG1 (Cell Signaling, 9408), MGMT 
(MyBioSource, 9409314), LONP1 (Cell Signaling, 28020), TFAM (Origene, AP26439), METTL3 
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(Abcam, ab195352), METTL14 (Millipore, ABE1338), YTHDF1 (Origene, TA347608), YTHDF2 
(Origene, TA331921), ALKBH5 (Millipore, ABE1013), and FTO (ThermoFisher, PA1-46310) at 
1:1000 dilution and incubated for 18 hours at 4 °C with shaking.  
4.7.4 RNA extraction and q-rtPCR 
RNA extraction and q-rtPCR were performed as explained in Chap 2. For tissue analysis, 
powdered tissue samples, instead of cell pellets, were used to prepare the samples. The 
additional primers are listed below in the format described in the first row: 
[Gene], [PubMed Gene ID], [Forward primer sequence], [Reverse primer sequence].  
Ndrg1, 17988, cgagagctacatgacgtgga, aagagggggttgtagcaggt. 
Mgmt, 17314, aaacactgaccccacagagg, aacacagggtgatggagagc. 
◦ ◦ ◦ 
Methods for the isolation of primary fibroblasts, fibroblast cell culture, and statistical analysis 
were presented in Chap 2.  
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Chapter 5 -  Discussion 
5.1  Improved mitochondrial stress response in long-lived Snell dwarf mice 
Compared to tests in lower organisms, life-span experiments on mice are more expensive and 
time consuming. Accordingly, only a small percentage of null mutations of interest are tested 
for their pro-longevity effects in mice. As a complementary approach, comparison of long-lived 
mice to matched controls focusing on specific molecular pathways can provide useful insights 
into the molecular mechanisms involved in increased mouse longevity. In this work, we used 
Snell dwarf mice to assess whether improved mtUPR is a feature of one of the longest-lived 
single-gene mutant mouse models.  
5.1.1 Primary fibroblasts from Snell mice are resistant to mitochondrial stress 
Higher resistance of primary fibroblasts isolated from Snell and Ames dwarf mice to cellular 
stressors such as UV light, heat, paraquat, hydrogen peroxide, and cadmium has been noted 
previously (Murakami et al., 2003; Salmon et al., 2005). Paraquat induces mtUPR in C. elegans 
(Yoneda et al., 2004). Hence, it is likely that increased resistance to paraquat may, in principle, 
stem partially from elevated mtUPR. Nevertheless, it has not been known whether fibroblasts 
from long-lived mutant mice exhibit improved resistance to mitochondrial stress.  
132 
 
We show that primary fibroblasts isolated from Snell mice are resistant to mitochondrial stress, 
specifically the effects of doxycycline on cell viability (Fig. 2.9A-B), cellular ATP content (Fig. 
2.10A), and oxidative respiration (Fig. 2.12, 2.13A-B). Consistent with increased resistance to 
mitochondrial stress resistance, we detected elevated levels of mtUPR proteins HSP60 and 
LONP1 in Snell fibroblasts (Fig. 2.1, 2.2), despite comparable mitochondrial abundance in 
normal and Snell fibroblasts (Fig. 2.3, 2.4). 
5.1.2 Snell cells exhibit elevated mtUPR independent of mitochondrial stress exposure 
In comparison to normal fibroblasts, Snell fibroblasts exhibited elevated levels of mtUPR 
proteins even when the cells are not exposed to mitochondrial stress (Fig. 2.1-2, untreated 
cells; Fig 2.3). We considered the possibility that the process of fibroblast isolation or cell 
culture conditions might induce mitochondrial stress, and the difference in mtUPR levels might 
reflect a stronger stress response in Snell cells.  
Cells respond to acute mitochondrial stress by transcriptional induction of Hsp60 and Hsp10, 
which leads to increased protein synthesis (Martinus et al., 1996; Zhao et al., 2002). Without 
stress exposure, both Hsp60 and Hsp10 mRNA levels were almost the same in Snell and normal 
cells (Fig. 2.6A-B, untreated cells), suggesting that even if the cell culture conditions caused 
mtUPR induction, the effect did not differ between two groups. Interestingly, doxycycline 
exposure increased Hsp60 and Hsp10 mRNA levels ~2.2-fold and ~1.7 fold respectively, in both 
Snell and normal cells, indicating that mtUPR response at the transcriptional level was 
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comparable in the two groups (Fig. 2.6A-B). As transcriptional upregulation also caused an 
increase in the protein levels, HSP60 protein levels in Snell cells remained higher than those in 
normal cells (Fig. 2.1B). Taken together, these observations suggest that elevated HSP60 
protein expression stems from either upregulated translation of Hsp60 transcripts or an 
increase in the stability of HSP60, suggesting a permanent change in mtUPR protein regulation 
in Snell cells. 
5.1.3 The mechanism underlying elevated mtUPR in Snell fibroblasts remains elusive 
Our analyses in HEK 293 cells deficient in METTL3 expression suggest that, although Lonp1 
mRNA bears a 5’UTR consensus motif for m6A modification, LONP1 protein synthesis is not 
regulated by m6A-CIT in these cells (Fig. 4.3). It is possible that LONP1 synthesis in Snell mouse 
fibroblasts might be altered by their upregulated expression of METTL3 and METTL14, but our 
data do not address this directly. Our attempts to silence Mettl3 expression in Snell fibroblasts 
by transfection were not successful. The possible role of m6A-CIT in regulation of LONP1 protein 
levels in Snell fibroblasts can be assessed in future studies by knocking-down METTL3 
expression using lentiviral transduction. For now, how Snell fibroblasts maintain elevated levels 
of HSP60 and LONP1 without an increase in corresponding mRNA levels remains elusive.  
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5.1.4 Tfam and Pgc-1α, indicators of mitochondrial biogenesis, are upregulated in response to 
mitochondrial stress in Snell fibroblasts 
We found that, in response to mitochondrial stress exposure by doxycycline treatment, mRNA 
levels of Pgc-1α, the main regulator of mitochondrial biogenesis, were upregulated exclusively 
in Snell cells (Fig. 2.7 B). Snell-cell-specific induction of Pgc-1α was also detected at the protein 
level and was not specific to the agent used to induce mitochondrial stress (Fig 2.8A-B). 
Upregulation of genes involved in mitochondrial biogenesis in response to mitochondrial stress 
has not been reported previously. Indeed, in normal fibroblasts, we did not detect an increase 
in mRNA or protein levels of Pgc-1α upon mitochondrial stress exposure. Only in Snell cells did 
we see Pgc-1α upregulation after doxycycline and thiamphenicol treatments.  
Our analysis, however, does not answer whether upregulation of Pgc-1α and Tfam expression is 
an important factor for increased mitochondrial stress resistance in Snell fibroblasts. 
Assessment of individual roles of HSP60, LONP1, TFAM and PGC-1α in mitochondrial stress 
resistance by knock-down protocols would be challenging, since these proteins are 
indispensable for cell function. It is plausible that the improved mitochondrial stress resistance 
observed in Snell cells may reflect the combined effects of mtUPR and mitochondrial 
biogenesis. The elevated mtUPR in Snell cells may decrease the response time to mitochondrial 
stress and minimize irreversible protein aggregation, while in parallel the mitochondrial pool 
may be replenished through concurrent upregulation of the mitochondrial biogenesis pathway.  
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5.1.5 Is mitophagy elevated in Snell cells? 
Alternatively, Snell cells may have elevated mitochondrial turnover. In support of this idea, the 
ratio of mitochondrial protein synthesis rate to DNA synthesis rate is higher in Snell heart and 
muscle (Drake et al., 2015). Since we observe indications of elevated levels of mitochondrial 
biogenesis in doxycycline-treated Snell fibroblasts (Fig. 2.7) without a detectable increase in 
mitochondrial mass, the rate of mitochondrial clearance may be upregulated as well. It is likely 
that mitophagy plays an active role in restoring mitochondrial homeostasis after mitochondrial 
stress exposure in Snell cells.  
Mitophagy is a term coined to describe selective degradation of mitochondria by autophagy (I. 
Kim, Rodriguez-Enriquez, & Lemasters, 2007). As opposed to mitochondrial biogenesis, 
mitophagy functions in the degradation of mitochondria to adjust mitochondrial abundance 
and in elimination of damaged mitochondria (Suen, Narendra, Tanaka, Manfredi, & Youle, 
2010). Mitophagy and mitochondrial biogenesis are required to maintain steady-state 
mitochondrial turnover and mitochondrial function (Palacino et al., 2004; Stichel et al., 2007). 
Thus, the combined effects of elevated mitophagy and upregulated mitochondrial biogenesis 
may provide a possible mechanism for maintained mitochondrial function in Snell cells. 
Mitophagy is preceded and promoted by mitochondrial fission, which divides long 
mitochondrial bodies into smaller pieces to be engulfed by autophagosomes, and also leads to 
isolation of damaged sections of individual mitochondria (Twig et al., 2008). This mechanism 
provides a measure to estimate the level of mitophagy. Cells and tissue samples can be fixed, 
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stained with mitochondria-specific markers, and examined under microscope to assess 
mitochondrial size and number. The presence of small globular mitochondria high in abundance 
in one group of cells, as opposed lower number of large, elongated mitochondria in another 
group of cells, would suggest that the cells in the first group are more likely to have activated 
mitophagy. Although mitochondrial morphology provides some clues on mitophagy, it is far 
from being conclusive, and requires additional measures for confirmation.  
PARKIN is an E3 ubiquitin ligase (Shimura et al., 2000), the mutant form of which can cause 
early onset hereditary forms of Parkinson’s disease (Kitada et al., 1998). Upon loss of 
mitochondrial inner membrane potential, PARKIN is recruited to the outer mitochondrial 
membrane (D. Narendra, Tanaka, Suen, & Youle, 2008), where it ubiquitinates mitochondrial 
substrates (Geisler et al., 2010). PARKIN-mediated ubiquitination is thought to serve as a 
marker for mitophagy-mediated recycling of mitochondria, since it is followed by degradation 
of target mitochondria (Geisler et al., 2010; Derek Narendra, Kane, Hauser, Fearnley, & Youle, 
2010). Accordingly, PARKIN localization to mitochondria can be used as a marker of mitophagy 
initiation, and can be utilized as an additional indication of mitophagy in future studies to test 
whether mitophagy activity is elevated in tissues of Snell mice in comparison to those of normal 
mice.  
One problem with this approach is that PARKIN localization may imply mitophagy initiation but 
does not guarantee complete execution of mitophagy-mediated mitochondrial degradation 
(Geisler et al., 2010). Therefore, microscopic analyses of mitochondrial morphology and PARKIN 
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localization should be utilized as pre-screening tools, and positive results should be followed up 
by the assessment of mitochondrial turnover, which can be measured by protein labeling and 
pulse-chase experiments as discussed in section 5.2.2.  
5.1.6 Effects of GH/IGF-1 and TH signaling on PGC-1α expression 
In keeping with data from Snell fibroblasts, we observed that Pgc-1α mRNA levels in Snell liver 
were 5-10-fold higher than those in normal controls (Fig. 3.1B). To a lesser extent, PGC-1α 
protein levels were also elevated in Snell liver (Fig 4.2A-B). Previously, elevated Pgc-1α 
expression was reported in liver and kidney of GHR-KO mice (Al-Regaiey et al., 2005; Gesing, 
Bartke, et al., 2011), which also have defective growth hormone signaling and show lifespan 
extension, suggesting that the mitochondrial biogenesis pathway may be regulated by GH/IGF-1 
signaling. Supporting this idea, mice over-expressing GH show decreased Pgc-1α expression (Al-
Regaiey et al., 2005).  
GH/IGF-1 signaling promotes mTORC1 activity through the IGF-1R/PI3K/AKT pathway. 
Accordingly, Snell mice, which are deficient in GH/IGF-1, exhibit downregulated mTORC1 
signaling. It is believed that mTORC1 activity promotes mitochondrial biogenesis by 
upregulating Pgc-1α (Cunningham et al., 2007; Laplante & Sabatini, 2013). Intriguingly, despite 
GH/IGF-1 deficiency and consequent downregulation of mTORC1 activity, Snell mice and GHR-
KO mice still exhibit elevated Pgc-1α expression. Calorie restriction, which induces robust 
lifespan extension in wild-type mice, also upregulates PGC-1α protein levels in liver (Al-Regaiey 
138 
 
et al., 2005) despite a suppressive effect on mTORC1 activity. Thyroid hormone (TH) signaling, 
specifically 3,5,4’-triido-L-thyronine (T3), upregulates both Pgc-1α (Weitzel, Radtke, & Seitz, 
2001) and Tfam expression (Garstka, Facke, Escribano, & Wiesner, 1994). Although Snell mice 
are deficient in thyroid hormone secretion, they still have upregulated levels of Pgc-1α. Overall, 
these observations in long-lived mice suggest that neither TH nor mTORC1 activity is required 
for Pgc-1α or Tfam upregulation. It seems likely that Snell mice activate an alternative pathway 
independent of GH/IGF-1 and TH signaling to upregulate mitochondrial biogenesis, which might 
be essential for lifespan extension.  
5.1.7 Snell mice show improved mtUPR induction in response to in vivo doxycycline 
treatment 
The role of mitochondria on health and lifespan gained attention when unbiased RNAi screens 
in C. elegans showed that at least one third of the longevity-associated genes encoded proteins 
required for mitochondrial function (Hamilton et al., 2005; S. S. Lee et al., 2003). Upregulation 
of mtUPR emerged as a mechanism linking changes in the mitochondrial protein stoichiometry 
to nematode lifespan extension (Durieux et al., 2011). This view was further supported by the 
observation that over-expression of a single mtUPR gene was sufficient to extend life span in C. 
elegans (Yokoyama et al., 2002).  
Mutations in gene encoding clock abnormal protein 1 (clk-1), a mitochondrial protein involved 
in ubiquinone biosynthesis, extends lifespan in C. elegans. Mclk1+/- mice deficient in Mclk1, 
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mouse ortholog of clk-1, also show lifespan extension. RNAi mediated inhibition of genes 
encoding subunits of the mitochondrial respiratory chain extends C. elegans lifespan (Hamilton 
et al., 2005; S. S. Lee et al., 2003). In mice, deletion of Surf1, a putative mitochondrial 
respiratory chain gene, also extends lifespan. Similar longevity effects of defective 
mitochondrial protein expression in C. elegans and mice suggest that lifespan extension in 
Mclk1+/- and Surf1-/- mice may be mediated by mtUPR. However, in vivo mtUPR levels are not 
investigated in either model. We observed that, while both basal and stress-induced mtUPR 
levels were elevated in primary fibroblasts isolated from Snell mice, in vivo mtUPR levels in 
Snell liver were higher than those in normal controls only after doxycycline-induced 
mitochondrial stress exposure (Fig 3.4). Assessment of mtUPR in Mclk1+/- and Surf1-/- mice, as 
well as in other long-lived mouse models ‒ not only at the basal level, but also after acute 
mitochondrial stress exposure ‒ may provide invaluable insights into the involvement of mtUPR 
in mammalian aging. 
5.1.8 Snell mice might maintain respiration rates after stress exposure 
In primary fibroblasts, we analyzed both mtUPR and mitochondrial function after exposure to 
mitochondrial stress. Elevated levels of mtUPR in Snell cells suggested that Snell cells might be 
resistant to mitochondrial stress. As expected, after doxycycline exposure, Snell cells preserved 
mitochondrial function as indicated by maintained ATP content and respiration rates compared 
to normal cells. Our in vivo analysis, which demonstrated 4-5-fold higher levels of mtUPR 
induction upon doxycycline treatment, suggests that Snell mice might also be protected from 
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mitochondrial stress at the organismal level. Although we have not addressed this suggestion in 
the current study, it warrants consideration for the future studies. 
5.1.9 While mitochondrial damage increases, mtUPR weakens with age; improved mtUPR 
might help prevent the former 
The first indications of age-related decline in mitochondrial health came from histological 
studies of human and rat tissue samples fifty years ago (Tauchi & Sato, 1968). Mitochondrial 
function declines in liver (Yen, Chen, King, Yeh, & Wei, 1989), heart, skeletal muscle (Short et 
al., 2005), kidney , and brain (Ojaimi, Masters, Opeskin, McKelvie, & Byrne, 1999) during aging, 
while mitochondrial stress increases through accumulation of defects such as mtDNA mutations 
(Corral-Debrinski et al., 1992; Yen, Su, King, & Wei, 1991), damaged mitochondrial proteins 
(Bakala et al., 2003), and loss of mitochondrial proteostasis (Benzi et al., 1992).  
Despite an increase in the mitochondrial stress load during aging, a corresponding increase in 
the mtUPR has not been reported. On the contrary, LONP1 activity in rat liver is 49% lower in 
old animals (Bakala et al., 2003). In mouse skeletal muscle, Lonp1 expression decreases with 
age (Bota, Van Remmen, & Davies, 2002), and this age-related decline can be totally prevented 
by caloric restriction at a level that extends rodent lifespan (C. K. Lee, Klopp, Weindruch, & 
Prolla, 1999). Recent evidence suggests that reversal of the age-related decline in mtUPR may 
prove beneficial for mammalian health: muscle stem cells from old mice show decreased 
expression of mtUPR genes Hsp60 and Hsp10, and nicotinamide riboside treatment starting at 
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old age (22-24 month old), which reverses this decline in the mtUPR pathway, induces 
neurogenesis and increases mean lifespan of old mice (H. Zhang et al., 2016). Snell mice exhibit 
improved capacity to induce both HSP60 and LONP1 levels in response to acute mitochondrial 
stress (Fig 3.4D). Importantly, increased mtUPR induction, by doxycycline, is detected in young 
adult mice with the Snell mutation. As it precedes the onset of age-associated mitochondrial 
deteriorations, improved mtUPR might provide enhanced protection against mitochondrial 
stress and may have a role in healthspan extension in Snell mice. 
Our results indicate improved mtUPR in the liver of Snell mice in response to doxycycline-
induced mitochondrial stress and provide a rationale for future mouse lifespan experiments 
involving compounds, like doxycycline, that induce mtUPR. Preliminary data from ongoing 
experiments in our lab suggest that acute exposure of normal adult mice to mild mitochondrial 
stress by doxycycline-supplemented diet may induce an upregulation of genes found to be 
elevated in Snell mice, such as Pgc-1α (Data not shown). Further experiments are required to 
understand the effects of transient mitochondrial stress exposure in mammals. 
5.1.10 Minocycline-treated mice 
Minocycline, like doxycycline, is an antibiotic of the tetracycline family. Minocycline 
(C23H27N3O7) and doxycycline (C22H24N2O8) have similar molecular structures with four carbon 
rings (Fig. 5.1), and they both inhibit mitochondrial (and bacterial) translation by binding to the 
smaller subunit of the mitochondrial ribosome. Although it has not been demonstrated yet, 
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given its inhibitory effect on mitochondrial translation, it is highly likely that minocycline 
treatment induces mtUPR. Importantly, minocycline extends lifespan in C. elegans and 
Drosophila. The effect of minocycline on mouse lifespan is currently being tested as a part of 
Interventions Testing Program (ITP). This study may provide valuable insights into the role of 
the mtUPR in mammalian lifespan.  
 
Figure 5.1 Molecular structures of doxycycline and minocycline 
One of the possible outcomes, i.e. detection of prolonged lifespan in minocycline-treated mice 
in comparison to the control group, would support the hypothesis that inhibition of 
mitochondrial translation might extend mammalian lifespan. In this positive scenario, it would 
be of interest to investigate several endpoints to examine whether the longevity effect may be 
due to mtUPR upregulation, as in the case of C. elegans. Since tissue samples from minocycline 
treated mice will be available for follow up studies, the analysis of frozen tissue samples to 
measure basal mtUPR levels in minocycline-treated mice will be possible. However, one should 
be cautious against premature interpretation of such analyses depending solely on basal mtUPR 
levels. Our results from Snell mice demonstrate that long-lived mice may exhibit unaltered 
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levels of basal mtUPR and still have an improved capacity to induce mtUPR upon mitochondrial 
stress exposure. Accordingly, minocycline-treated mice should also be examined for their 
capacity to induce mtUPR, which would require preparation of an additional mouse colony of 
minocycline-treated and control mice for in vivo treatments. A possible experimental approach 
could be feeding 6-month old mice on minocycline/control diet for 6-12 months, followed by 
acute mitochondrial stress treatment (for example by 2-week doxycycline treatment) and 
measurement of mtUPR protein levels in tissue samples. 
The other possible outcome, i.e. detection of no effect or a negative effect of minocycline 
treatment on mouse lifespan, would be equally informative. In this negative scenario, analysis 
of mito-nuclear protein stoichiometry and mtUPR levels in minocycline-treated mice would be 
critical for the interpretation of the results. If no alteration in basal or induced mtUPR levels is 
detected in the experimental group, then no conclusion can be made for the effect of mtUPR in 
mouse lifespan. It would merely indicate that minocycline treatment at the selected dose does 
not induce mtUPR in mice. On the other hand, if mtUPR is upregulated with no longevity effect, 
the interpretation would be complex and further analysis would be necessary to reach a 
conclusion. While it may well be the case that mtUPR upregulation does not prolong mouse 
lifespan, it is also possible that the minocycline dose might be too high so that consequent 
mitochondrial damage might not be reversed by mtUPR. Such an effect could be confirmed by a 
sharp decrease in mtDNA-encoded respiratory chain protein levels in minocycline-treated mice. 
Alternatively, chronic inhibition of mitochondrial translation - even if it is tolerated by the 
mitochondria - might gradually induce detrimental effects in tissues with high energy demand 
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such as brain and muscle. In these scenarios, where either the drug dose or the treatment 
length is not ideal, a modified lifespan study with a lower dose of minocycline, a shorter 
treatment period, or a treatment regimen with alternating periods of minocycline/mock 
treatments may be required to observe a prolongevity effect. 
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5.2  m6A-mediated cap-independent translation in long-lived Snell mice 
In this work, we presented evidence indicating that the m6A-CIT pathway is upregulated in long-
lived Snell dwarf mice. Previously, NDRG1 and MGMT, which are involved in DNA damage 
repair, were found to be upregulated in Snell liver (Dominick et al., 2017). We demonstrated 
that protein levels of NDRG1 and MGMT are regulated by m6A-CIT in cultured HEK 293 cells, 
suggesting that m6A-CIT may have a role in their upregulation in mouse tissues as well. In 
addition, our work on mitochondrial stress response in Snell mice revealed that elevation in 
protein levels of mitochondrial protease LONP1 are not accompanied by a comparable increase 
in Lonp1 mRNA levels, suggesting that LONP1 protein levels might be upregulated by increased 
translation. Although Lonp1 mRNA has a consensus motif for m6A modification and is listed 
among putative m6A-CIT targets, we were not able to detect an effect of Mettl3 inhibition on 
LONP1 protein levels in HEK-293K cells, indicating that LONP1 is likely not regulated by m6A-CIT 
at least in HEK cells. On the other hand, we confirmed that TFAM and PGC-1α are partly 
synthesized through m6A-CIT. Hence m6A-CIT may also have a role in upregulated levels of 
TFAM and PGC-1 in Snell liver.  
5.2.1 Implications of the upregulated m6A-CIT pathway in Snell mice 
Discovery of m6A-CIT is very recent. Although the presence of N6-methyladenosine residues in 
eukaryotic mRNA has been known since seventies (Desrosiers et al., 1974; Perry & Kelley, 1974; 
Perry et al., 1975), their function remained elusive for the next forty years. The use of 
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transcriptome-wide high-throughput sequencing techniques developed in the new millennium 
revealed ubiquitous distribution of m6A modifications along mRNA transcripts. m6A marks are 
found in 5’UTR, exon, intron, and 3’UTR fragments of ~7K mature mRNA sequences in HeLa 
cells and mouse tissues (Dominissini et al., 2012; Meyer et al., 2012). However, the role for N6-
methyladenosine residues located in 5’UTRs of mRNAs in a hitherto unknown mechanism of 
cap-independent translation was discovered only three years ago, and led to the identification 
of N6-methyladenosine-mediated cap-independent translation (Meyer et al., 2015; J. Zhou et 
al., 2015).  
Implications of our findings indicating elevated m6A-CIT in Snell mice are broader than its 
possible role in NDGR1, MGMT, TFAM, and PGC-1α expression. In principle, elevated m6A-CIT 
activity may result in upregulation of thousands of additional putative targets of m6A-CIT 
functioning a variety of pathways including heat shock response (J. Zhou et al., 2015). So far, 
aside from our data confirming NDRG1, MGMT, TFAM, and PGC-1α as m6A-CIT targets, only 
HSP70 (J. Zhou et al., 2015) has been demonstrated to be synthesized through m6A-CIT. As the 
list of confirmed m6A-CIT targets grows in the future, so will the list of candidate proteins 
whose protein levels may be upregulated in long-lived Snell mice.  
5.2.2 Increased protein stability as an alternative mechanism 
Four out of five proteins for which we noted elevated protein levels in Snell mice without 
comparable levels of upregulation in mRNA levels (NDRG1, MGM1, TFAM, and LONP1) include 
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DRACH consensus motif in the 5'UTRs of the corresponding mRNA transcripts, suggesting that 
they are putative targets of m6A-CIT (Linder et al., 2015; J. Zhou et al., 2015). Tempted by this 
fact, we focused on translational regulation as a candidate mechanism for the discrepancy 
noted between the protein and mRNA levels. However, our findings do not rule out alternative 
mechanisms, which deserve further attention.  
One such mechanism involves a decrease in the rate of protein turnover. Select proteins in Snell 
mice may have longer half-lives, resulting in increased protein stability and higher 
protein/mRNA ratios, independent of translation. This hypothesis can be tested by protein 
labeling or chemical inhibition of translation. Radioactive isotopes are widely used for protein 
labeling. In this approach, the cells are incubated in a medium supplemented with amino acids 
containing radioactive isotopes, for example 35S methionine. This step, where 35S methionine is 
incorporated into newly synthesized proteins, is followed by incubation of cells in fresh medium 
with non-labeled amino acids. The relative proportion of radioactively labeled proteins in cells 
collected at later time points depends on the protein stability. Proteins of interest can be 
immunoprecipitated and the ratio of radiolabeled proteins can be assessed by measurement of 
radioactivity, which positively correlates with protein stability, and negatively correlates with 
the rate of protein degradation. Analysis of normal and Snell cells by this method would allow 
comparison of relative stability of individual proteins in two cell populations.  
Alternatively, chemical inhibition of translation, for example by cycloheximide treatment, 
followed by analysis of protein abundance at a later timepoint could reveal how fast a protein is 
148 
 
degraded. However, inhibition of translation might induce cellular stress, and result in 
transcriptional upregulation of stress genes such as Lonp1. Unless translation mechanism is 
blocked completely, transcriptional upregulation can increase protein abundance, making it 
harder to interpret the results. Simultaneous inhibition of both transcription and translation 
can be suggested, however, this might be toxic for cells, and induce unintended effects.  
5.2.3 m6A-CIT upregulation may be a shared feature of long-lived mutant mice 
Following up on our work, Dr. Garcia investigated levels of proteins regulating m6A-CIT pathway 
in two more long-lived mouse models. In summary, compared to control mice, both GHR-KO 
and PAPPA-KO mice exhibited elevated levels of m6A writers (METTL3, METTL14) and readers 
(YTHDF1, YTHDF2), but either downregulated or unaltered levels of m6A eraser proteins 
(ALKBH5, FTO) in liver, kidney, and skeletal muscle tissues, suggesting that m6A-CIT 
upregulation is not limited to Snell mice (Ozkurede et al. manuscript under review). 
5.2.4 Upregulation of m6A-CIT might be induced by inhibition of cap-dependent translation 
Inhibition of cap-dependent translation by the synthetic molecule 4EGI-1, which suppresses 
recruitment of the translation initiation complex to 5'-cap, induces upregulation of NDRG1, 
MGMT, TFAM, and PGC-1α both in primary fibroblasts and in liver of normal mice (Ozkurede et 
al. manuscript under review). Moreover, mRNA levels of the m6A writer Mettl3 are also 
upregulated after 4EGI-1 treatment, suggesting that m6A-CIT pathway may be induced when 
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cap-independent translation is inhibited. Analysis of protein levels of m6A-CIT regulators is 
required to test this idea, and is currently in progress.  
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5.3  Final remarks 
I find it helpful to compare mitochondria to nuclear power plants. They both increase energy 
production enormously. However, they have to be maintained with extreme care. As defective 
mitochondria can lead to loss of a cell, a damaged nuclear power plant can devastate a whole 
city. Also, once a city develops relying on nuclear power as its main energy source, it cannot 
sustain itself without such an energy resource. The same is true for mitochondria. Mitochondria 
and nuclear power plants can harm the ecosystem they inhabit both when they misfunction 
and when they do not function at all. Accordingly, it is not surprising that cells have a specific 
mechanism to respond to mitochondrial stress, and that this mechanism is found to be 
enhanced in a long-lived mouse model.  
While current findings suggest a positive correlation between mtUPR and mouse lifespan, there 
is a lot to be discovered before one can speculate on ways to enhance mtUPR to increase 
lifespan and improve health in mammals. How is mtUPR regulated? Is overexpression of a 
single component of mtUPR, such as, HSP60 is sufficient to increase mammalian lifespan? Can 
we fine-tune the expression levels of individual mtUPR proteins? Does elevated mtUPR have 
negative health effects? Is it more advantageous if mtUPR is upregulated temporarily or only in 
specific tissues?  
Given the progress on mtUPR research during the first two decades following its discovery, 
there is enough reason to be optimistic that we will be able to answer many of these questions 
in the near future. 
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